**SUSTAINABLE TECHNOLOGY ADOPTION SCORE: 75/100**

Technology Adoption: 18/25  
Innovation Leadership: 18/25  
Measurable Impact: 17/25  
Future Strategy: 14/15  
Industry Position: 8/10

Summary assessment: Pfizer has a well‑developed, well‑funded program to deploy sustainable technologies across energy supply (large VPPAs + on‑site renewables), energy efficiency and process improvements, green chemistry and sustainable packaging. It is delivering measurable reductions and supplier engagement, and it has a clear, ambitious roadmap (net‑zero by 2040). Pfizer is among the stronger pharmaceutical companies on sustainable technology adoption and collaboration (e.g., Energize), but it is not uniformly the pace‑setter on all metrics (some peers have faster renewable‑electricity penetration and site‑level clean‑energy deployment). See detailed evidence and scoring rationale below.

Findings by research area (evidence 2022–2025)

Key Technologies Adopted (25 pts) — score: 18/25
- Renewable electricity procurement at scale: Pfizer has executed multi‑year virtual power purchase agreements (VPPAs) to cover large portions of its electricity demand — a 15‑year VPPA with Vesper Energy for Hornet Solar in West Texas (310 MW; intended to cover North American purchased electricity) and a set of 15‑year VPPAs in Europe with Bruc for ~124 MW of new solar near Seville to cover EU purchased electricity (announced 2021→2023 contract activity; projects operational timing 2023–2024) [Vesper/Hornet VPPA](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGmLgNNpvryQ9O1addI5Tha1GffQkmPAEP5p2r_ZK3svXNt8LuA2rgjm0r038oOiqJ1OrDnSEOav9ptDdYCSI7AS1nlDNt9Hs1swT5wmBVPwq9E8R6IqrEtX-k_x4jIRF7Ji8F5OZn0VuNnAFsUCofBWZwXDw9QXbSSpR8Q7tgzR-3WVUQEUY7YgHsedtO2VrZWjom70R_kFZ8fA0hgvvXKQhujtvQT_nmI-3qj1Eac8J02A==) [EU VPPAs with Bruc](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_H1du9HG1hTlDb6FieVD8o6jS3Dsuz5zQCauNpWp2kNgJCOn1eKbfv8CPbWbJEK24pbm8j3CO3Zfh-VsALYpkEGC_20WgFa_jTizgD4HttA4SgT6rs5Fw9vqoZJ9O9KZTyBIHg115JfA1KQpegpLy2lrXLe0gWnO7WlZDbYnSOXjc20nScFGWMgtYydpewrF_kT2oXETPE631g6hc_eVHdwVeS9RHgwArFWZ5y31GTsc=) [Pfizer renewable targets / RE100](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEmja5hyNOBIIBz1s1c88TP4X5oO5qEVUSwgy3F573iZbkQdnQelZ8kPNPcNimQy67IEvZCFI2FrW5RMqAuqybuqy4ma2jLPCcJ7TRSnmYCiM6aLN66PFvNxdwEpe0nFBtCkUIwvnLkgGTDBjT6z4sJ72HgEIjxU-X8JrBRYD0hDUeDIJwVyuydRaRXDvY0yVUXjwETnUZRfvsrw2a8aD-Of8LLHqEQ9F9NkXN7Y33UtbuC1ZXq4M4N).
- On‑site renewables and facility electrification: examples include on‑site wind turbines (Puurs, Belgium) and multiple solar installations (California, Connecticut, Italy, Singapore, China) and other site renewables cited in Pfizer site summaries and press materials [Puurs wind / site renewables](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHaGfSDq0XRD0dpJIw38fzWQXNaevFdIFjyd_t2kLyRsjFX5WxmDryDAlRq4HpPvKMxkBeYvgRs-izNlgnk8OvG1pCk5MacQOXlF97k5eMq7gEQ0bRi-oqZ9bqNbqcafbtjoCbenGq-dgKWzmEE--Z1oHYqXIWNBJLRcQ6MPAnQdYpfH0QPH_dZyAeKsQ4ANAIVeMwwk5zKP2fX8SfoR8hoMLDxJlPdog==) [site list & renewables](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHaGfSDq0XRD0dpJIw38fzWQXNaevFdIFjyd_t2kLyRsjFX5WxmDryDAlRq4HpPvKMxkBeYvgRs-izNlgnk8OvG1pCk5MacQOXlF97k5eMq7gEQ0bRi-oqZ9bqNbqcafbtjoCbenGq-dgKWzmEE--Z1oHYqXIWNBJLRcQ6MPAnQdYpfH0QPH_dZyAeKsQ4ANAIVeMwwk5zKP2fX8SfoR8hoMLDxJlPdog==).
- Energy‑efficiency and digital energy management: deployment of Ever.Ag (virtual metering / energy‑manager) with reported >$8M annual energy savings across sites; AHU/filter upgrades and other efficiency projects delivering multi‑million GBP/USD savings at R&D/manufacturing sites; a new energy‑efficient Nitrogen Generation plant installed in 2022 reduced electricity use at a site [Ever.Ag energy manager savings](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1Y2kUayh1jb-X7xUJEsj71FNBQF9SbWJ-oGfJs_wcPeHCRhMdOrIb__3ble_do_HxGALY0O9GylbBzF9ovDdENDIobPpZ4gt6Op6SRb2orHXnDJOdg3DGYO_5riGI5o-9kOUvYubwzpf3ag==) [Camfil AHU project](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHsFcaP4agXzlv-51QJ7LWQTU7bdEX5IQcOQg_Qbre5iOHZqoJXJkOUWzZfPMxOZ4dkLadhWBmdZLHV-Hqw3vJhWya8pJEspnWLXhntE1eagogP50rWYqyILntCde1QV40i9TQ6tvk-f7baZnQviCjoinbbafU=) [Nitrogen plant (2022)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFg4OzoYh5RuuxCMrjd2CvLbs9Bna0SH_-te8zuEjkTo23M0O8xlhBx4DBeZUV2um7uQhTDy1h354FfW0zCUR9ihwMridS2AVua8_bowkTfild1ooDh9JllaYS-Q2RB3LKJQGfUxYRQSNN_Rexo-pZo3YvdCV_mqXujx65m).
- Low‑carbon manufacturing/process improvements: green chemistry and biotechnology program (process changes, solvent substitution, catalysts, process intensification/continuous manufacturing) are embedded in R&D and manufacturing [Green chemistry program](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFVUfv005s4vXzYv0CVFlOajaJTImq1E_cm_Dqm-Tnuzb89-3a6_Qc19GClsjhcqmuYVP9hgw3trEZxuHONCByRAfWlUfrafSoBwAzZNqD3fWsGznLtc4o7XSutPfMef9A8vx3hK6a5sDP7jkk8obZwFAZZJnE6DOHfFwOIAFcJ29qCNdK5zQ==) [process intensification / continuous manufacturing](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEgO599jKHS-TocVt0NPlw8Vsgo9PabPZr5I5j4UoWv50CVJaI1aFKkL_LFjQkhiJGkMdDZEfOiGEbK2xQBc9tNv-cxL8E7dEsdSyTWMqwb6iKWkt_13DO_mvgi_DNNac6T9dcx8bNygt37X-I43QAhqca4OiJo).
- Circularity and packaging: Sustainable Packaging Team, Green Packaging Design Guidelines, and digital tools (e.g., Pfizer Clear) to estimate packaging Scope‑3 emissions and drive reductions [Sustainable packaging / Pfizer Clear](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHcPjSLoSJlUILA8uGrzCLDo8xEjiOSJxVeI8iTJtal_UUZolElG7ItwOCt5G4rvKkJuat_dX7xFMNB67U2ODF4hIZZ-R3Ng8-9Nch_VKhK2CDiFEEmDneiztQT-LD6r5Yz) [Pfizer centre one / packaging efforts](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEk7_bZ7mf8cr4-sfsQSTop-6vl9gFOjLZnxgrRIcNjpOdaQOC3dYJVqrgMDbS8esACIRWv8CqkuzA2WHYFvs5vvXlvv8XY4kc5BjPtNBUK3wyO_gb028sWghzYLjR2kUWybKynoi9MlZzNtxVTag==).
- Other: internal carbon price ($200/mtCO2e) applied to capital decisions; sustainability bonds ($1.0–1.25B) used to fund green projects and facility design [internal carbon price](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEPMbUyOMfpDKUfqHGf_5Ysb6UCVGtB8mjHB4zr9xB2dzaM2ea10m2LcpF47ONdGFSUbeNT_sPAV47uvWgKSdOUczDN1xqISvnJD9YyqfZafNZD5xv4YES5MzPIjg8uavc5feib7n-EKU1iJY6KdJGD) [sustainability bonds](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi).

Why 18/25: Pfizer has implemented multiple advanced technologies (large VPPAs, on‑site renewables at key sites, digital energy management, green chemistry/process intensification) across its operations with significant operational integration. It falls short of the top band (20–25) because on‑site renewable penetration and proprietary breakthrough manufacturing technologies are not uniformly deployed at scale across every site (some metrics show renewable electricity still in early years of scaling) [Pfizer renewable progress / 2023–2024 data](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGRUsL9D5P3c9Zulto5e34eFgsN2VVFhJEfYFgfQSC1GKf5-ePBtwCx_RuH_kDcQLRwlbi9SiI9vppunYm-VV1Somr08ykZ5CSHaZ52VewRt4y9il1YiL5GhKJ7tKy8igf_F6jzI7CSnNEPfg2B3t3tsjf6bUSDp2Niy3gNjEUF5xj2oMd6rz6hXwUmz8bdyq0E5w=).

Innovation Leadership (25 pts) — score: 18/25
- R&D & process innovation: Pfizer’s Green Chemistry & Biotechnology program and investments in process intensification and continuous manufacturing demonstrate in‑house technical work to reduce environmental footprint of medicines and manufacturing [Green chemistry & biotech](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFVUfv005s4vXzYv0CVFlOajaJTImq1E_cm_Dqm-Tnuzb89-3a6_Qc19GClsjhcqmuYVP9hgw3trEZxuHONCByRAfWlUfrafSoBwAzZNqD3fWsGznLtc4o7XSutPfMef9A8vx3hK6a5sDP7jkk8obZwFAZZJnE6DOHfFwOIAFcJ29qCNdK5zQ==) [process intensification](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEgO599jKHS-TocVt0NPlw8Vsgo9PabPZr5I5j4UoWv50CVJaI1aFKkL_LFjQkhiJGkMdDZEfOiGEbK2xQBc9tNv-cxL8E7dEsdSyTWMqwb6iKWkt_13DO_mvgi_DNNac6T9dcx8bNygt37X-I43QAhqca4OiJo).
- Partnerships and ecosystem programs: Pfizer is a founding collaborator of Energize (industry collaboration to decarbonize supplier electricity via renewables), has entered partnerships with Flagship Pioneering, CytoReason, UC San Diego CTI, and brokered strategic vendor relationships (Schneider Electric, Vesper Energy, Bruc) to scale clean energy procurement and digital energy solutions [Energize & supplier engagement](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGSy_YtktfKVydbMI6sfA7QtKSQWTD0GzNGI3WWPtCwiQfyg9hfgInTZzcRiz2rLogyftty0bciZaHbrg1x0fL7xdnoeDqbbNOohGbpO0dwgipgb_itJd_5uboDBpxnSuLMQ4y5YgKJnv2xNPivpkpAZeP_2Dmhn6oaly8gJWYNRmBbUUOFhg2qRWOAnDHH_-rDgwhHvC5qMgM=) [Flagship Pioneering partnership](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFC-xHNRBEO23GJ7NCArqZvOQ2MSoPbtWC2t_NruWGBvImsu2d9M1eZz8f3Zyn6Xa_uAbesLyfD0l52bf0YzFo56juyP4ubkgE4kJDiQJvGSXPrTBD7yVa6cLHe61t0PamNZOrp82d9LMZatS3HiK147M2ZcrTp7Y2W7wwgfhA=) [CytoReason partnership](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGW03dPW2bTF2e48-ijTBOHagQffxPKkd-5T1fJhtuoyhWGQrCkHFDvlcHXLL3O-7MhgWkhCqSgado6NRQatrj9DrFBCEQpv63bMDojCYeaBO7dM6um3QokgNQ30cjAvygEhZSmD_14P05J_QhJbnnGFjOlCtsKxa6u3gm9dssxMrWxjgLczIovJpksFRBTS5onsrUOFyifsOK9aJfCb_d4-4E=) [VPPA partners / Schneider broker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_H1du9HG1hTlDb6FieVD8o6jS3Dsuz5zQCauNpWp2kNgJCOn1eKbfv8CPbWbJEK24pbm8j3CO3Zfh-VsALYpkEGC_20WgFa_jTizgD4HttA4SgT6rs5Fw9vqoZJ9O9KZTyBIHg115JfA1KQpegpLy2lrXLe0gWnO7WlZDbYnSOXjc20nScFGWMgtYydpewrF_kT2oXETPE631g6hc_eVHdwVeS9RHgwArFWZ5y31GTsc=).
- Digital/AI use for efficiency: Pfizer reports use of digital tools, AI and digital twins to model processes, forecast carbon outcomes and optimize operations — an important lever for sustainable tech adoption [digital / AI tools](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGt1awUhvCR-dwkCvjHfS7GC9Zru5QAfr8E3dAWgu5RvumC9CsibgAAxxFx8ybDpiZURmUyhuoXPz1rOwNWeVb2esQyQj7xFv3vRhLn6eDFbPNJrzcziR-KVr7eGp9RscXGxnkNTx0Ne6peuLIVp40kff0g7sFGEg_B6LcALFNlHlyq9FYGg-TKFAoQgwSH0r9jGMuu).
- Scale & IP: Pfizer invests heavily (sustainability bonds, CapEx) and has SBTi‑aligned targets, but there is less public evidence of large numbers of proprietary green‑technology patents or single‑company, ground‑breaking low‑carbon manufacturing platforms that would justify the top innovation band.

Why 18/25: Pfizer shows strong innovation activity — internal R&D applying green chemistry, active partnerships and industry collaborations, and digital/AI adoption — putting it in the “strong innovation program” band. It stops short of the 20–25 “proprietary breakthrough patent” band because public evidence points to collaborative/policy/operational innovation rather than many disclosed proprietary breakthrough sustainable‑tech patents in the public domain [Pfizer R&D & partnerships](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF2_nhZ7WOuihAnOg2lOitW5xQSC7XOTwufG55WW05f3fz9AM9ao6fXawHtVlre-5mhX6SqdNEBsIVlHuJV__LkhBaeXES3qDJb5cVjtDcWNF04XycvBDWha3hdM7UbycPdRrEnkZc9xZ5rL1lyu7G4atbgaMTER9SIi4unRr1eVYQstRrXzEFxMa_4dNVM51nfKCCgKV1N23jMxlfh8as42WgEeBQ9ugNfaJmTP1Z-lg==) [Energize & supplier initiatives](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGSy_YtktfKVydbMI6sfA7QtKSQWTD0GzNGI3WWPtCwiQfyg9hfgInTZzcRiz2rLogyftty0bciZaHbrg1x0fL7xdnoeDqbbNOohGbpO0dwgipgb_itJd_5uboDBpxnSuLMQ4y5YgKJnv2xNPivpkpAZeP_2Dmhn6oaly8gJWYNRmBbUUOFhg2qRWOAnDHH_-rDgwhHvC5qMgM=).

Measurable Impact (25 pts) — score: 17/25
- Documented GHG reductions and renewable progress:
  - Pfizer target: net‑zero by 2040 (95% company, 90% value‑chain reductions vs 2019) and interim Scope 1&2 reduction of 46% by 2030 [net‑zero & interim targets](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtdW-1XVJA9YmbmGHeAl5c0kERKxO0-TBnr7WlUTzdpZ9_BrrZmxuele7kdX3JOlftyL_IgxZoOgO99wpkmjdbaccdfNpkKWnMIZxHtq_MejGT4WXksBKrbwHSdRJpkeJaP4LOlA24hNNBedw4bR6tLnyr1ykqDMdkPVJYpDAYY_gW7738XESjEn95f_OIzWBEYO195oe48Q==) [2030 interim target](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi).
  - Reported Scope 1 & 2 reductions: mixed but measurable — e.g., 13.9% reduction in Scope 1 & 2 GHG in 2023 vs 2019 (Pfizer reporting), 18% reduction vs 2019 reported in some analyses for 2022; long‑term (2000–2020) >60% reduction in Scope 1 & 2 [2023 scope reduction 13.9%](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWR_A9htgs8KxihJQM8BhAQgnN8HnNCu798datrSialDN8DYlOcvvXxXbJ48PA2DNKrF_GO6y9TpBd2sOhXdQEF1PMSzqiyZCIZM-eSilBqx0BxYrS8RysSoUIUigtDuhlt23QmTs=) [2000–2020 >60% reduction](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtdW-1XVJA9YmbmGHeAl5c0kERKxO0-TBnr7WlUTzdpZ9_BrrZmxuele7kdX3JOlftyL_IgxZoOgO99wpkmjdbaccdfNpkKWnMIZxHtq_MejGT4WXksBKrbwHSdRJpkeJaP4LOlA24hNNBedw4bR6tLnyr1ykqDMdkPVJYpDAYY_gW7738XESjEn95f_OIzWBEYO195oe48Q==) [2022/2021 figures](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH4G1mdYyBv2MwuOAvl2I_gjwFvkEEUeInxiXIhqUuNLC1f1mIDTv9K4LrBgG6oH4A0YigYOxf8Z-owMbtZJVTsJ4bDPiQN4tfpah96-P1cLN3LP5N6eudGKK5xKj7f4xZZzFwu8FIQ4-7EPUDoQ_9E6TRjC4nnwQ==).
- Renewable electricity progress: Pfizer reported 10% renewable electricity in 2023 and 14% in 2024 in some disclosures; other aggregations note broader figures (e.g., 57% by 2023 in some datasets) — showing progress but variability by accounting method and market coverage [2023–2024 renewable % reports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFAQscg4IJKSZzx5nZo3Hpk4ev--Q0J4j2qxHuqLdxvoLDt9on9k5HdMc0x1H3eS3g4zrimndnsrsmuemVetEzTI82LOK8yMirbOkhOrWImgY39J23SDC5Vi-cc3Hz86psbooxzTw99wvzoUOfaDOh6W5b8QY9pKDPfUVOxV7WJWHu7I2Bmz0UROBdd9yw2T1VKBag=) [2024 14% figure](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGRUsL9D5P3c9Zulto5e34eFgsN2VVFhJEfYFgfQSC1GKf5-ePBtwCx_RuH_kDcQLRwlbi9SiI9vppunYm-VV1Somr08ykZ5CSHaZ52VewRt4y9il1YiL5GhKJ7tKy8igf_F6jzI7CSnNEPfg2B3t3tsjf6bUSDp2Niy3gNjEUF5xj2oMd6rz6hXwUmz8bdyq0E5w=) [57% claim (dataset)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHiBeNeVVs07KLnSL9D9QSb-Nxn7ltjyR-o3LqADEzl5-t1_tTQiJVQKr0xRcK8ZmQkimf_S2ze9m28YLZDHLfabGJI4DDpUWGf8IXxK8vtu_UVKMwu030sZ2wIODbOKCzGVx4YwAO4Reje14O5JQRea105Q6TH0A==).
- Quantified project savings: energy conservation projects historically reduced CO2 by large absolute volumes (e.g., 120,000 tCO2e from >500 projects through 2009), more than 4,000 GHG reduction projects since 2000, and reported site‑level financial savings (e.g., >$8M/yr energy savings via Ever.Ag) [project CO2 & savings](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHYh3ZliXdT2oXiqC3zInvwXWxY0RYmP9E7APMWSmv4nyFYiPMEE9ND9I9QpEjffKVtBiuep6O2Vi3lLAoEIoDUC7_Kq5vmbPfrVeyr2067zsOGqHMSS9VmMQKmY-QnusUzwQfEbue7La1-1qkonxq27K9dm88IzRpWr4ubSK8l7qhhQ-3W-buAJ7ToUnx-MQUiOxOpVM3eo8Gn_q7hvAata3ij) [Ever.Ag savings](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1Y2kUayh1jb-X7xUJEsj71FNBQF9SbWJ-oGfJs_wcPeHCRhMdOrIb__3ble_do_HxGALY0O9GylbBzF9ovDdENDIobPpZ4gt6Op6SRb2orHXnDJOdg3DGYO_5riGI5o-9kOUvYubwzpf3ag==).
- Supply‑chain engagement: supplier commitments — Pfizer aimed for 64% of purchased‑goods suppliers (by spend) with science‑based targets by 2025 and reported ~65% supplier commitment in 2024 — a measurable lever for Scope‑3 reductions [supplier targets 64% by 2025](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi) [65% supplier commitment 2024](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGumf00oEt-DnhGTmLEXbqTrYbcT0_R9QB6bvEKYSGTRQY73ad288EswxzdwOv0Mk-P_jSjy8LQx4vmL-ciazYWq87VdaW8OgMqTFP7hHRfbOqc25mn3sm0y24spohxdKzItbs97E0oIPZ2z2UoSG81v09tRoH4w2R_DPVV9cv8XGKz).
- Other measurable metrics: business travel emissions down substantially (e.g., reported 55% lower than 2019 baseline in some filings), water withdrawals and waste disposal also showing reductions (water withdrawal down vs prior baselines; hazardous/non‑hazardous waste down ~13% vs 2020) [business travel reductions](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHk4r3Vm22bqzECKEoWfTrUaM7tRJHqSEokhG321dVVDUt5t3cBsfHofwqPWVBMJITlMhqKb42iEH0mMRfoYeNR3KWzKn8frwFBEUlVj3pQ_UtnpZhpC7d41o2Jg7_WGenHttd3jdEmFz1nYUecY4cZAXQ9rwI=) [water & waste improvements](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFrDUvG15JUlQBdHE5AJg1WgzDK7eJ9wPBNdEVF4szU7yNntKMFPrFHDiQRvg1yf8bRIxN3z6RkBpvzjaC488NZIR0gERDhkmiKyFD_cMDBFXJgfrNAQ_aHyn-vjXG7x8anIcjaxjVkjwqARRJNJ1F1xbYy4jY61xi8lJEyzb8LW5vUZaXaCp1ivHHWCJfjlOI=) [waste reductions](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHU3-yef8etHzo4E9ZDfQCil-dv9YPlM59lQd1Jiautc6i6Hk8y4zmWxNt2PKJXVV2jUGVVTZKgaBxlNOrj4vZ8qVKGVbz4XcVyZIZihrBEVKheEoqwI3hB17wln747sygZqmtiHqF2lGmiSE_NdbsAAsf1qVNH2RQib44T2598d2ru91QWG7-A).

Why 17/25: Pfizer has clear, documented, verifiable measurable impacts (Scope 1&2 reductions, supplier engagement, project‑level energy and cost savings). The magnitude is significant but generally in the mid band (10–50% improvements, varying by metric and baseline), not the >50% across recent years band required for the top score in this rubric [Pfizer impact reporting (ESG/Impact reports, CDP)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFz2X08ol6p5XxdfDfqT-MVTy2CxZx5NBh_jDz48H4NUdGucWcvsd3k8eqz8Ur9nwXCSaIfV1sL2IWzpMKRCuq3afinPKqcMu_Lqhsl2el0ivn2nrW28J48UUVicYabyGhO1uc10qVpXdx9qUEBKrIe6WpcvKDoVqFA0t7ysJFn74OsFVmM0SqHjTKpE21RJRxcS51oEEK6ZdT-wmIJiijoOEaVoXBHmFQ_d3SF1VTe1fs=) [CDP & SBTi alignment](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEXQcemX-JwRhs0oae83xxvPLAI4XKZn3_nfugGSqvScyTsW0QjDf-SUUDZvRItaXKaTXJ5cdogRtU5RErF5aeMEwL3iWhD3qrz4CHrB40R3V1OIAGkJbJ2Im4UW4X3FpSVtX5ZKA-_H4-cJvAEVq6EK-Aw).

Future Strategy (15 pts) — score: 14/15
- Documented roadmap and targets:
  - Net‑Zero (SBTi Net‑Zero Standard) by 2040 (95% company, 90% value chain reductions from 2019) [net‑zero by 2040 / SBTi alignment](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtdW-1XVJA9YmbmGHeAl5c0kERKxO0-TBnr7WlUTzdpZ9_BrrZmxuele7kdX3JOlftyL_IgxZoOgO99wpkmjdbaccdfNpkKWnMIZxHtq_MejGT4WXksBKrbwHSdRJpkeJaP4LOlA24hNNBedw4bR6tLnyr1ykqDMdkPVJYpDAYY_gW7738XESjEn95f_OIzWBEYO195oe48Q==) [SBTi validation history](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFVD7Yjv_-FfCg5pAhqqQpFsxNpjI4JDZ59rU_meZW70zHsh85RuGr5jIH_LeUPCvPidWav0hVBhatqs5wmFCVcvxqRx6LE8Wv1q7vLgzQct8JylOeIljisWxgC8Db79tvRoB0uIDrpNBxnzm4Y3F4IN6Uwudpf9SnB_6X_-jR5TKDdf7swxAsvxjoieVc8soPdulqqj_SWbw0cYdLpv_yHhy_BSDG-GcMZ7yYHiDA=).
  - Interim 2030 target: reduce Scope 1 & 2 emissions 46% vs 2019; 80% renewable electricity by 2025 and 100% by 2030 (RE100) [2030 interim targets & renewables](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHjD-qQhaMCxIxZbHO09om_2j48Y30v78xf1i3p2W22yWyHZA5hTw8PX5hfQiYEh5IHkl2Tzm1L2i9ofCpJg4y9-Q7WWqTkzejL467z45-LUxh7JHQWm1bFhVRfy90K8do8TxBnMcGU-hutFw3EyM-tyBQfBXe1VdXtCg==) [RE100 membership & targets](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEmja5hyNOBIIBz1s1c88TP4X5oO5qEVUSwgy3F573iZbkQdnQelZ8kPNPcNimQy67IEvZCFI2FrW5RMqAuqybuqy4ma2jLPCcJ7TRSnmYCiM6aLN66PFvNxdwEpe0nFBtCkUIwvnLkgGTDBjT6z4sJ72HgEIjxU-X8JrBRYD0hDUeDIJwVyuydRaRXDvY0yVUXjwETnUZRfvsrw2a8aD-Of8LLHqEQ9F9NkXN7Y33UtbuC1ZXq4M4N).
  - Supplier engagement goals (64% suppliers by spend with science‑based targets by 2025), logistics and business travel reduction targets for 2025 [supplier target & 2025 goals](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi) [business travel & logistics targets](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6FkftPSj8ZFHv0fvxbpdmRD0ETKgl-dFd---h6EdDGDX760Tzwo6bV2gfG-wLm7oaxTR3jEoybzf1mEjQmrhZwmTQuBhaF3Cl-kZem-GrbivdqFJMjq2cUedHvSCl5aY4qRaw8UpzhmIbgWkEjZZl5tCLBz_VB_ATUA==).
  - Financing and governance: sustainability bonds to fund projects, Board oversight and integration with TCFD disclosures and executive KPIs [sustainability bonds & financing](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi) [governance & TCFD](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFRmZn68ySyd-9jFy9gT93nsLmCSb1sQNzg1xsAlReA1BGhJL5DJrdPd7_cC0eVH77QPaovxFSNRg9GGNACQqbMvaprr_jXGN4XktH2o932v7zSl1fLR-QNUvDFOggjnBREtQ==).
- Roadmap clarity and resourcing are strong and well documented in Pfizer ESG/Impact reports and public commitments.

Why 14/15: Pfizer has a comprehensive, specific roadmap with concrete targets and financing mechanisms, and board/compensation alignment. It loses a point only because the 2030 renewable/electricity progress shows implementation challenges in some markets — i.e., ambitious targets are clear and funded, but execution has mixed year‑by‑year progress for purchased electricity in some disclosures [Pfizer Impact/ESG reports & updates](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFz2X08ol6p5XxdfDfqT-MVTy2CxZx5NBh_jDz48H4NUdGucWcvsd3k8eqz8Ur9nwXCSaIfV1sL2IWzpMKRCuq3afinPKqcMu_Lqhsl2el0ivn2nrW28J48UUVicYabyGhO1uc10qVpXdx9qUEBKrIe6WpcvKDoVqFA0t7ysJFn74OsFVmM0SqHjTKpE21RJRxcS51oEEK6ZdT-wmIJiijoOEaVoXBHmFQ_d3SF1VTe1fs=) [2023–2024 renewable progress reporting](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGRUsL9D5P3c9Zulto5e34eFgsN2VVFhJEfYFgfQSC1GKf5-ePBtwCx_RuH_kDcQLRwlbi9SiI9vppunYm-VV1Somr08ykZ5CSHaZ52VewRt4y9il1YiL5GhKJ7tKy8igf_F6jzI7CSnNEPfg2B3t3tsjf6bUSDp2Niy3gNjEUF5xj2oMd6rz6hXwUmz8bdyq0E5w=).

Industry Position (10 pts) — score: 8/10
- Relative strengths: Pfizer is among the better‑performing large pharma companies on sustainable‑tech adoption — large corporate VPPAs, supplier engagement programs (Energize), SBTi‑aligned net‑zero target (ambitious 2040) and major finance instruments (sustainability bonds) put it in the top tier [Energize & supplier work](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGSy_YtktfKVydbMI6sfA7QtKSQWTD0GzNGI3WWPtCwiQfyg9hfgInTZzcRiz2rLogyftty0bciZaHbrg1x0fL7xdnoeDqbbNOohGbpO0dwgipgb_itJd_5uboDBpxnSuLMQ4y5YgKJnv2xNPivpkpAZeP_2Dmhn6oaly8gJWYNRmBbUUOFhg2qRWOAnDHH_-rDgwhHvC5qMgM=) [net‑zero target & SBTi](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtdW-1XVJA9YmbmGHeAl5c0kERKxO0-TBnr7WlUTzdpZ9_BrrZmxuele7kdX3JOlftyL_IgxZoOgO99wpkmjdbaccdfNpkKWnMIZxHtq_MejGT4WXksBKrbwHSdRJpkeJaP4LOlA24hNNBedw4bR6tLnyr1ykqDMdkPVJYpDAYY_gW7738XESjEn95f_OIzWBEYO195oe48Q==).
- Relative gaps vs peers: several peers (AstraZeneca, Novartis, GSK, Johnson & Johnson) have in some cases achieved higher purchased renewable electricity penetration earlier (e.g., AstraZeneca ~95% in 2023, Novartis >90% purchased renewables 2023, GSK high percentages) or have aggressively deployed on‑site renewables and other clean technologies [AstraZeneca renewable progress](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFSf_jk2a4Kuqenm9-H8vBG55MK0kDGPxnpK33uTJiEw8G1AXCCTACP4Ga9g_v5PfJ-FhJZT6qvuUbf2bvlKLpsMTeJwmLyUyat-9SAM9cHJdR7D032-mdVOqfteuTO7-l6rXiN21Us8EbFMS_iN9sbzWBi5cr0zyOJFmqOafoqhQfJ__zLQsd4_SMCCnwXP_PYwD8SPWsr908=) [Novartis renewables 2023](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFoswd5AF0yvf7r5nPkwH4d3twJiAy-VN3cOKEkp_xdbPZw3BmC7WcZK2hohfnP_NKr4de9jLJJC0WnbqJ-w8bhYEKLjQCfAFZKDFMt6YZsK5gWT5juqRwF7s3Bzmb4omyR3R_yJd_G-H8epoyOFs1gQbFyNNXXSRJCaJkPgkkqfHJzzdAFwWXUguasjPqCZeJtAtcDxlM=) [GSK renewable targets & progress](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHpflUZ_GDLQpcF2Nu2keu8TU9iVBHkiFqLwImS8ONavo1a1_geCO427Ahfa9IyL7lauGIVqMa_gk_zrXkeirqWICBvlDMcQ3_Pv9L4GcfpdWyH0ef89jiEKViJUxMWIprm10d4sp6vtT8OlUR9KxVKdl6RCY3hYSI=) [J&J on‑site renewables](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFjsekejASMzMdnn90nbULdeLlSuF5ybYEgkcjogVEJpstpydJOQDd4NedMUeb0BaU1aX-LQnPhPDPNbHkiYzyx9YvZgsJZ2j8z_PUSslYJa676-cCryU9ekHuycc3siE_ENi-e279XkKM4UBEmcwApvKtEwSKeqMRxijkCowZDpajcPatGQ5TVsxG4t-n1u8pGQLBMEqqPVIYFQrJKRcVghltGzG8=).
- Standing: among top performers but not clear industry setter on every metric (renewable penetration and some site‑level deployments lag a few peers), therefore “among top performers” rather than unequivocal sector leader.

Why 8/10: Strong positioning — large deals, supplier programs, SBTi/net‑zero ambition — but peers lead on a few operating KPIs (purchased renewable electricity %) and have sometimes faster on‑site renewables deployment, so Pfizer is “top‑tier” but not sole leader [peer benchmarking summary](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGnHkJdhWtOSP4vjeHObIMiggoD2ti_zbBvixD2V130wOgwkgTE8lrTSMU1rlnZWhZYe17tEZZfa5NIJhmHpL6Udd0nd1v7ccwFAE2rBCNElBKR68M6KWJMWR5TehOVF32jtyx_kLMtlrkfDSvP6J6kgmfemUU8D9n8J01lUNVBQa8kKvWswfXibk2ugi5q).

Scoring recap and arithmetic
- Technology Adoption: 18/25  
- Innovation Leadership: 18/25  
- Measurable Impact: 17/25  
- Future Strategy: 14/15  
- Industry Position: 8/10

Total = 18 + 18 + 17 + 14 + 8 = 75 / 100

Selected recent examples and metrics (2022–2025)
- Vesper Energy VPPA (Hornet Solar): 15‑year VPPA for ~310 MW solar to serve North American purchased electricity; project operational timing around end of 2023 (Pfizer used this to significantly expand renewable procurement) [Vesper/Hornet VPPA](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGmLgNNpvryQ9O1addI5Tha1GffQkmPAEP5p2r_ZK3svXNt8LuA2rgjm0r038oOiqJ1OrDnSEOav9ptDdYCSI7AS1nlDNt9Hs1swT5wmBVPwq9E8R6IqrEtX-k_x4jIRF7Ji8F5OZn0VuNnAFsUCofBWZwXDw9QXbSSpR8Q7tgzR-3WVUQEUY7YgHsedtO2VrZWjom70R_kFZ8fA0hgvvXKQhujtvQT_nmI-3qj1Eac8J02A==) [VPPA press & coverage](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEBipexSKtXbQvWR216BoEQOxCTtjVcnm_1ijLgEzsHZCwdLlzvl6bakL6XkSI16zZaOs0jQCFvMQw4K5meOCRhqDlP3HVo7P-73giY_mhOXJR9_GJQLtanqgtoZaC4gFF0Q2u0_VMFPAHyEQ22IV8cmINZJX1Oqan5m2zM).
- European VPPAs (2023): ~124 MW in four new solar projects in Spain with Bruc under 15‑year contracts covering EU purchased electricity equivalent for manufacturing/R&D/commercial sites [EU VPPAs with Bruc](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_H1du9HG1hTlDb6FieVD8o6jS3Dsuz5zQCauNpWp2kNgJCOn1eKbfv8CPbWbJEK24pbm8j3CO3Zfh-VsALYpkEGC_20WgFa_jTizgD4HttA4SgT6rs5Fw9vqoZJ9O9KZTyBIHg115JfA1KQpegpLy2lrXLe0gWnO7WlZDbYnSOXjc20nScFGWMgtYydpewrF_kT2oXETPE631g6hc_eVHdwVeS9RHgwArFWZ5y31GTsc=) [Bruc / Schneider brokered deals](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_H1du9HG1hTlDb6FieVD8o6jS3Dsuz5zQCauNpWp2kNgJCOn1eKbfv8CPbWbJEK24pbm8j3CO3Zfh-VsALYpkEGC_20WgFa_jTizgD4HttA4SgT6rs5Fw9vqoZJ9O9KZTyBIHg115JfA1KQpegpLy2lrXLe0gWnO7WlZDbYnSOXjc20nScFGWMgtYydpewrF_kT2oXETPE631g6hc_eVHdwVeS9RHgwArFWZ5y31GTsc=).
- Renewable electricity progress: various reported values depending on accounting — Pfizer-reported ~10% renewable electricity in 2023 and ~14% in 2024 in some disclosures, with Pfizer target of 80% by 2025 and 100% by 2030 [2023–2024 renewable % reports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFAQscg4IJKSZzx5nZo3Hpk4ev--Q0J4j2qxHuqLdxvoLDt9on9k5HdMc0x1H3eS3g4zrimndnsrsmuemVetEzTI82LOK8yMirbOkhOrWImgY39J23SDC5Vi-cc3Hz86psbooxzTw99wvzoUOfaDOh6W5b8QY9pKDPfUVOxV7WJWHu7I2Bmz0UROBdd9yw2T1VKBag=) [2024 14% figure](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGRUsL9D5P3c9Zulto5e34eFgsN2VVFhJEfYFgfQSC1GKf5-ePBtwCx_RuH_kDcQLRwlbi9SiI9vppunYm-VV1Somr08ykZ5CSHaZ52VewRt4y9il1YiL5GhKJ7tKy8igf_F6jzI7CSnNEPfg2B3t3tsjf6bUSDp2Niy3gNjEUF5xj2oMd6rz6hXwUmz8bdyq0E5w=) [renewable targets](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEmja5hyNOBIIBz1s1c88TP4X5oO5qEVUSwgy3F573iZbkQdnQelZ8kPNPcNimQy67IEvZCFI2FrW5RMqAuqybuqy4ma2jLPCcJ7TRSnmYCiM6aLN66PFvNxdwEpe0nFBtCkUIwvnLkgGTDBjT6z4sJ72HgEIjxU-X8JrBRYD0hDUeDIJwVyuydRaRXDvY0yVUXjwETnUZRfvsrw2a8aD-Of8LLHqEQ9F9NkXN7Y33UtbuC1ZXq4M4N).
- Emissions reductions: Pfizer reported ~13.9% reduction in Scope 1 & 2 GHG emissions in 2023 vs 2019 baseline; longer‑term reductions >60% from 2000–2020 in company reporting [2023 scope reduction 13.9%](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWR_A9htgs8KxihJQM8BhAQgnN8HnNCu798datrSialDN8DYlOcvvXxXbJ48PA2DNKrF_GO6y9TpBd2sOhXdQEF1PMSzqiyZCIZM-eSilBqx0BxYrS8RysSoUIUigtDuhlt23QmTs=) [2000–2020 reduction history](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtdW-1XVJA9YmbmGHeAl5c0kERKxO0-TBnr7WlUTzdpZ9_BrrZmxuele7kdX3JOlftyL_IgxZoOgO99wpkmjdbaccdfNpkKWnMIZxHtq_MejGT4WXksBKrbwHSdRJpkeJaP4LOlA24hNNBedw4bR6tLnyr1ykqDMdkPVJYpDAYY_gW7738XESjEn95f_OIzWBEYO195oe48Q==).
- Energy efficiency savings: Ever.Ag deployment has been credited with >$8M annual energy savings across Pfizer sites; Camfil AHU/filter improvements produced millions in projected savings at Sandwich (UK) R&D campus [Ever.Ag savings](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1Y2kUayh1jb-X7xUJEsj71FNBQF9SbWJ-oGfJs_wcPeHCRhMdOrIb__3ble_do_HxGALY0O9GylbBzF9ovDdENDIobPpZ4gt6Op6SRb2orHXnDJOdg3DGYO_5riGI5o-9kOUvYubwzpf3ag==) [Camfil savings](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHsFcaP4agXzlv-51QJ7LWQTU7bdEX5IQcOQg_Qbre5iOHZqoJXJkOUWzZfPMxOZ4dkLadhWBmdZLHV-Hqw3vJhWya8pJEspnWLXhntE1eagogP50rWYqyILntCde1QV40i9TQ6tvk-f7baZnQviCjoinbbafU=).
- Supplier engagement: Pfizer hit ~65% of purchased‑goods suppliers (by spend) committing to science‑based targets around 2024 — meeting/exceeding its 2025 goal of 64% [supplier targets & progress](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGumf00oEt-DnhGTmLEXbqTrYbcT0_R9QB6bvEKYSGTRQY73ad288EswxzdwOv0Mk-P_jSjy8LQx4vmL-ciazYWq87VdaW8OgMqTFP7hHRfbOqc25mn3sm0y24spohxdKzItbs97E0oIPZ2z2UoSG81v09tRoH4w2R_DPVV9cv8XGKz) [supplier goals](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi).
- Corporate financing & governance: $1.25B sustainability bond (2020) and $1B (2021) used for green design and environmental projects; Board governance and TCFD alignment documented in ESG/Impact reporting [sustainability bond(s)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi) [governance & TCFD](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFRmZn68ySyd-9jFy9gT93nsLmCSb1sQNzg1xsAlReA1BGhJL5DJrdPd7_cC0eVH77QPaovxFSNRg9GGNACQqbMvaprr_jXGN4XktH2o932v7zSl1fLR-QNUvDFOggjnBREtQ==).

Strengths, risks and opportunities (high‑level)
- Strengths: large, structured renewable procurement (VPPAs) across regions; strong supplier engagement programs; formal SBTi/net‑zero commitments with concrete interim targets; meaningful project‑level energy efficiency and green chemistry programs; dedicated financing (sustainability bonds) and governance [Pfizer commitments & program elements](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtdW-1XVJA9YmbmGHeAl5c0kERKxO0-TBnr7WlUTzdpZ9_BrrZmxuele7kdX3JOlftyL_IgxZoOgO99wpkmjdbaccdfNpkKWnMIZxHtq_MejGT4WXksBKrbwHSdRJpkeJaP4LOlA24hNNBedw4bR6tLnyr1ykqDMdkPVJYpDAYY_gW7738XESjEn95f_OIzWBEYO195oe48Q==) [Energize / supplier engagement](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGSy_YtktfKVydbMI6sfA7QtKSQWTD0GzNGI3WWPtCwiQfyg9hfgInTZzcRiz2rLogyftty0bciZaHbrg1x0fL7xdnoeDqbbNOohGbpO0dwgipgb_itJd_5uboDBpxnSuLMQ4y5YgKJnv2xNPivpkpAZeP_2Dmhn6oaly8gJWYNRmBbUUOFhg2qRWOAnDHH_-rDgwhHvC5qMgM=).
- Risks / gaps: variation in renewable penetration by accounting method and region (a gap to close for 2025 renewable targets); limited public evidence of extensive proprietary, breakthrough low‑carbon manufacturing IP (Pfizer emphasizes process R&D and partnership models); Scope‑3 reduction will depend heavily on supplier transformation and market decarbonization [renewable accounting & progress variability](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGRUsL9D5P3c9Zulto5e34eFgsN2VVFhJEfYFgfQSC1GKf5-ePBtwCx_RuH_kDcQLRwlbi9SiI9vppunYm-VV1Somr08ykZ5CSHaZ52VewRt4y9il1YiL5GhKJ7tKy8igf_F6jzI7CSnNEPfg2B3t3tsjf6bUSDp2Niy3gNjEUF5xj2oMd6rz6hXwUmz8bdyq0E5w=) [scope‑3 dependence on suppliers](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGZH26fbuOfhmqzq2G7ABr6c7vN6loixasPa5F35dm4JfcLUnX-hE4ZaO49gmJxBgQGc5yRhGIfnbO-QMUuLgn24aW3yHQtUC6M0ALRLeTc2xVId6hmaCvYTXobW0LWB2yoy7kRSqoP4uKuzD2sb1ufq84dkJVyhLsLQBic9CNWFBMUw==).
- Opportunities: accelerate on‑site renewables and electrification where grid constraints limit VPPA effectiveness; expand demonstrator sites for low‑carbon continuous manufacturing as showcases to the sector; increase public disclosure of site‑level impacts and technology‑specific KPIs (kWh saved, tCO2e avoided per project).

References (all citations from the research summaries)
- [pfizer (0-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHBawA8KFp12k3awLkCUCpNnmBWUpNk5eN1zoToGz4srp3sr1_lxJUgRLjra3YBIE29UPtDfW9rWybtiGa1tJkj-2pnYWkpLX3eDvJtHujkJ12vAhaXuGor6LPV_5WLmyyXFHL_0LmhapGTiURBTVEMJzu-e8DuHsDZkagysY5xSHd6v1IrgsCAgfpFUxNm)  
- [pfizer (0-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF_K77U4UWYQ3KJxgimz8V2t5k94V53lMsll7STxXhRsqrDbLhWI_R-V_psjrRGVuySftbITbHsy7yA_ekMeOxBryoNgS-5fTbs8TiNR-nQJErbnV3ihmJEoCFlc05-zfRO2ttAWoxWLIgDY61O1tU5plM1yNwN6uj3CBE9x6INpTUMpZj6KTZFha2KfQokni8J3xDxU7u0Ovtz6YbsfkuibjisU_q5ee0uv5ZDzjOMUng=)  
- [carboncredits (0-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHxgigcp3cyuJ8CljcIZs76LXR7fthuPyNo5pY9MWr-bbIbQXid_SlXNU7mdAt_xVyjDDZ8FRGbOewyPNS3o_4JErFq5-nALWGFklfV4U9j9VaehrMvClzen28ezlnF5NL7kN31RWTQZOawET3qSgana00d8ncQ_ZXMmCzq)  
- [esgnews (0-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFNTHlIgo55Co6cCeq2wjE1vrSomGmvLOJVhdAXulyybFBYDcxITexSnv5CXhRU0TjGlj1JBqccOLCEnMO1VhGF5YRPIcd9Zw43opKS-sWaENRfZJA7ovrU9sUercYRPGujT7YXFkFPbAMh2wcc4CvmK2x5ySRTg-Gmo9azoOQU5pRPpqIhJPN7E699R9ptgUgL_YziKbXJE4KK8XpzV2QhbfCFNwH3-ZOEOS_yDAM=)  
- [dcfmodeling (0-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH4G1mdYyBv2MwuOAvl2I_gjwFvkEEUeInxiXIhqUuNLC1f1mIDTv9K4LrBgG6oH4A0YigYOxf8Z-owMbtZJVTsJ4bDPiQN4tfpah96-P1cLN3LP5N6eudGKK5xKj7f4xZZzFwu8FIQ4-7EPUDoQ_9E6TRjC4nnwQ==)  
- [aim2flourish (0-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH-tRtOh__oP-0rymkjGxBppeltBTCubfWCrc56C5r2tmU9qwzGj0y3-BKYw0py6J7aSaCiKfPv9wFjieVsQmQyHodyVrHgwZefR3K867MH09oZe-csp-Pw4LxVFElyqLEQm-jQp11GZ8q6K3BMSxFpnWMJp3BIw9KROkY881Pg0WH9ki0NsuZ62Ma9ovLZsjP2uzPb91wKlw==)  
- [pfizer (0-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGoGDyLowus9K0arhlSCDCTfcQITJjYPV3MJbO7U2WGm_8HhoV2tuSReGX_DJRTejBovGEZqJgijDm_CS_c8NKRlUXg-0D-8iF5WEX6T47dXc9EbbMrm4qKDN6G1OHD-xjlCZwmjqqERJhDHfVASJfTAuc20bPL5tuZlwLKcEO9ldRxnA==)  
- [net0tracker (0-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHNUUltw-ab49qpMbWDfQMePv78GGKp73jePVNRH5QbyCmdib-3gx-RjbSNnhIqmLTcX3ot80qwCz8wDvPb0gHepXrtt9wOmxIM_t5pdRy75rCPBWyLlvkQppNUPnFa38cnjiRcCyJoWE2N4JHXb76vjw==)  
- [pfizer (0-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFVUfv005s4vXzYv0CVFlOajaJTImq1E_cm_Dqm-Tnuzb89-3a6_Qc19GClsjhcqmuYVP9hgw3trEZxuHONCByRAfWlUfrafSoBwAzZNqD3fWsGznLtc4o7XSutPfMef9A8vx3hK6a5sDP7jkk8obZwFAZZJnE6DOHfFwOIAFcJ29qCNdK5zQ==)  
- [pfizercentreone (0-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEk7_bZ7mf8cr4-sfsQSTop-6vl9gFOjLZnxgrRIcNjpOdaQOC3dYJVqrgMDbS8esACIRWv8CqkuzA2WHYFvs5vvXlvv8XY4kc5BjPtNBUK3wyO_gb028sWghzYLjR2kUWybKynoi9MlZzNtxVTag==)  
- [pfizer (0-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHPgDcaMusHmDrI7mXZ8pfnbg5b-2F7Nv7mjduEhwzqf7sTJlgFBAldb47wGUEhMqmjwf6yuSzI9IKJSxx4F3wlS8ull9nJ23BaTzqex8gCTioCq6GwflRpSULE0bB2dHigR8Won3vxGrO0_N8V4mXhhkszoUZNO7nt3N50Nh3k3EGmGhoAD5YCUB3ZRHWS5d_G6-WTnha7ZdY=)  
- [carboncredits (0-2) duplicate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHxgigcp3cyuJ8CljcIZs76LXR7fthuPyNo5pY9MWr-bbIbQXid_SlXNU7mdAt_xVyjDDZ8FRGbOewyPNS3o_4JErFq5-nALWGFklfV4U9j9VaehrMvClzen28ezlnF5NL7kN31RWTQZOawET3qSgana00d8ncQ_ZXMmCzq)  
- [esgnews (0-3) duplicate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFNTHlIgo55Co6cCeq2wjE1vrSomGmvLOJVhdAXulyybFBYDcxITexSnv5CXhRU0TjGlj1JBqccOLCEnMO1VhGF5YRPIcd9Zw43opKS-sWaENRfZJA7ovrU9sUercYRPGujT7YXFkFPbAMh2wcc4CvmK2x5ySRTg-Gmo9azoOQU5pRPpqIhJPN7E699R9ptgUgL_YziKbXJE4KK8XpzV2QhbfCFNwH3-ZOEOS_yDAM=)  
- [impakter (0-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGJ_0sg6w6RM0QWjW0cxOwwwf4nItJ2uOMtBpMVHUSdEiSkKWjvNf000nJG1EwICMnmOaEP4c81vUB65cqtAiLTCmmWW6RBb_trVSTaJMHHYk8VexuhQxu0ELPZrL5Tny5ckTex8Q3rmomcSB2-Gt_ahpWi)  
- [europeanpharmaceuticalreview (0-12)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEP8f2oAsJevTKCm-fw4PKum19dq0qrZs7sHa8beATJfIdCDXebOMgK90olhj4zlUPQ81cI11iEtRpQLCQ3xkitFuhLXkbS7RLdcwaIXH5g2CZ9qcCEPLSc5cMd437DWzLSCxhYszaLzhZrruLWGUZqEzPI15IRvDEqvt9GS3J_i5iHuHCz4BrIrOptFVDysAfowKI7YC93D_i2bEg=)  
- [oneyoungworld (0-13)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGwGa-HbNuaVjKaPLwvDdg4sm3rGId_hwekj9MPpVAb_iAUCZXpIhPWeuxXbD4tLXVlFwC0I2f94siN_JsDXZ0CINY_7ev3AcXjQL3q9IERJuOlNFj5_eek1HM07aHLwbpJmahEPFfAd7i3ly5MNz8LuLkffNswcEbKvpzNweQTZ5vRbIKNcuAD2WuYgYX3DxL6rN4CBiQVAeIm7g==)  

- [europeanpharmaceuticalreview (1-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGlDbl0YEnrAvqMmn3nR_S0lTEMC6mnqGzzuQKXjLAwLY06d9S6tM9zRtHHzWPOsUoSZ_iiFEdmDYH-ZIsNz1VfgnSlx_8cS_AGLHEoETnfOxJHca_AEFhWUAs8eFGh9q2xezDRjlJI8FbI651pcvGSfV7PcgMJ9_z1hcT_IMpmSC8B3rZF-N-vnVy8dAns7gD1hPGkdV409AtDPeY=)  
- [pfizer (1-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGZH26fbuOfhmqzq2G7ABr6c7vN6loixasPa5F35dm4JfcLUnX-hE4ZaO49gmJxBgQGc5yRhGIfnbO-QMUuLgn24aW3yHQtUC6M0ALRLeTc2xVId6hmaCvYTXobW0LWB2yoy7kRSqoP4uKuzD2sb1ufq84dkJVyhLsLQBic9CNWFBMUw==)  
- [pfizer (1-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWR_A9htgs8KxihJQM8BhAQgnN8HnNCu798datrSialDN8DYlOcvvXxXbJ48PA2DNKrF_GO6y9TpBd2sOhXdQEF1PMSzqiyZCIZM-eSilBqx0BxYrS8RysSoUIUigtDuhlt23QmTs=)  
- [esgnews (1-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGhjM--cmQGS3ZIMoJpT1Z-5wqdXFNloscWABBW6pg0VhNGuKn-5gX5LULhLBK8tHFVCh-O3nSlkkGakTfj3L-X5Lxe34UkSXZ2y3BEEJOlu8p_bhVyaGY2LrPTbgqJJNmXmEvxLVrR4ESHkOX1ujHWwRsfS64HntyYopTW6w0PQHyIq8ahEHK_cAK5kt3esyTv3Li4yynRm34taKxM-BXhGQRhn5yvr2ooA3Y4IPU=)  
- [pharmadispatch (1-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFYZP0u8kc6geH14HHVg-Lti5nuAZWK5D-pGi1JiU24neEAC49gQK0NYlFb60HyJxD5kYixEl74jFjJEjIVPWxzHd6gWYrpLDoN3vVmTLOYQPMk7uzEnijeDdDc1jd4zYpKI20qMO4J6DkcPQXIJE2FSghb-76n_3oQxnlcjKDeLFHjDoizwLq3WG280dsCjopyA_NdGnBbnYoHiA==)  
- [pfizer (1-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_dsMfy_8LlEF4F1yzt8QlpSHy_gHh0DzSVs_DZO2vMK15kI8__3SjI3x9mVlyxObKz5fJ9rXeT9VeuUldjYnGlcMxIYfR5SJHb1G7x1DwhDuc6A7GZIh5vobcb00bGBuyhqlPi5i9rHa-VF7IWYmR-FC1ropDnU4LoemC0I3M)  
- [pfizereupolicy (1-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8E_caQLgIpHezydnuX95pD0u5pfQqo9x4xLbf2Sh0-_s77h6CpLZyMEPlXQy0oGgkNCjVWsPeK3zViPkmpQldFV9xu38Q7hcsTTTmzsPbIyU4gCTj8krtJbOnzC1AINHzPpJuorPrwlQok5GI7fNp5RUAqBT1Mj_LH1E=)  
- [pfizer (1-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFQEOjODYSFwnRkauvSTwJLCh1LOixavVOJPLNfaaw9IEyY2GAgF7KJ3nNa6lrgQcraYO9kt2tpilSL_Lon3TaiMG3BUfQMJjWHP3IzEgTdWOFTxu4diWQJ0V70OYxuhj6ad2K0-LRP9qzVXFtEKg9XB3G9oQMFfWm4Rc_uo7xzYj-oywq_UqA3J5cTVp-iK0Rc-QrD)  
- [pfizer (1-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF17EiLyZkk0vB6uEmGLSxjcGSUgW5CSbu3z1qX3lPN2u9pOFDElumnbu1aXwpBIyy18-j_7I8LI_8d5rZQjTBVWH9IjF_qeuvPyhMkf3HQgMtdSjm4ymjOO4QPlbv5DDI2jYvc0C8QQeqde1EVzOAJlXbAyp7xQKO_urm3XZDNZpnPuw==)  
- [csrwindo (1-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGyhA7f7ljV-pivq3P1gP4srBy-vL1gTGoa0K6IwtpdV7-Xp2Amf7IwOHeYEt2rErotbiu3dU_iqvm4QrQaFVOYbe6F1IpmqQrwwvPynn23I_04rgl06Or6m5VR_r54Ke3_NcUMZW_1Gub7SA0rdzsxY0hANDC4F9sv5lOMHl-Uv4N9ImJRbaZBFwODiKUeMlNu0IP6)  
- [publicnow (1-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGumf00oEt-DnhGTmLEXbqTrYbcT0_R9QB6bvEKYSGTRQY73ad288EswxzdwOv0Mk-P_jSjy8LQx4vmL-ciazYWq87VdaW8OgMqTFP7hHRfbOqc25mn3sm0y24spohxdKzItbs97E0oIPZ2z2UoSG81v09tRoH4w2R_DPVV9cv8XGKz)  
- [pfizer (1-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFZcpSjCRiYLqq1AysVAxDZ4ElpBto1Hse3Sv7Fjw4j5lR913AbPmvRYBZp13vE1QM_RxYLEGNYgJwc3q_VdYkBGNE4K6vtLjokulfmzdQ1wiA0Ng0sZ_pX-W1NZSejxC-u58zbrpO4hGj5sB1imAqSr3PTnr8XZeMow_u-npzoxOox74ge23qVSeteNPGzxZChHeXsUa80nPgn2uBnSUjGM7J_BrRmnovS)  
- [impakter (1-12)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE3BfTesX2OQLLwOv8u_BKxqKjILBkcF4sR6hj2UHNi0jO4XqQOkZd5emC6vt2uKM0DajAQHWSbRoAPEMIssk8HqvhPSAezOJKAq4xP0hTSb0s9HIunt5dNZdbkll9pRp71E2FoUBK7MB2u-0SNOUSvYYZD)  
- [pfizer (1-13)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFz2X08ol6p5XxdfDfqT-MVTy2CxZx5NBh_jDz48H4NUdGucWcvsd3k8eqz8Ur9nwXCSaIfV1sL2IWzpMKRCuq3afinPKqcMu_Lqhsl2el0ivn2nrW28J48UUVicYabyGhO1uc10qVpXdx9qUEBKrIe6WpcvKDoVqFA0t7ysJFn74OsFVmM0SqHjTKpE21RJRxcS51oEEK6ZdT-wmIJiijoOEaVoXBHmFQ_d3SF1VTe1fs=)  
- [scribd (1-14)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGMChehOAGbAi7ujKxXjouDpXm5doLE-7voWwhE_Kz_m6pEVW9TJxU0_Bt2F2zgBJfBR6rdrC7jJSmHosrPhQOEy23CWgW6AdQjyVlUiy6QuptCHYDEy6ErEHnqbW8N1GIMV82cvvowC7YEQWhUHFNT_YZVlwZFA8hzv8E=)  
- [pfizer (1-15)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFRmZn68ySyd-9jFy9gT93nsLmCSb1sQNzg1xsAlReA1BGhJL5DJrdPd7_cC0eVH77QPaovxFSNRg9GGNACQqbMvaprr_jXGN4XktH2o932v7zSl1fLR-QNUvDFOggjnBREtQ==)  
- [responsibilityreports (1-16)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGiOs_RjeJfE-oyMZ5YgoBoehclWKlNXEA5q0IloNZZFl0i6ne5TxgR4RrpL59KagvofKBOCgMw5NqIIuBq5lFsGC-O6hb_9V2d3-ypSuPFTv8tK0iS6VUAzy325gQicrAPfUDZxlM8lNNBj3efWGvJEG2)  
- [publicnow (1-10) duplicate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGumf00oEt-DnhGTmLEXbqTrYbcT0_R9QB6bvEKYSGTRQY73ad288EswxzdwOv0Mk-P_jSjy8LQx4vmL-ciazYWq87VdaW8OgMqTFP7hHRfbOqc25mn3sm0y24spohxdKzItbs97E0oIPZ2z2UoSG81v09tRoH4w2R_DPVV9cv8XGKz)  
- [marketscreener (1-17)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEmoaaXNM0S4RtdErVQ44hEqvq8oQu1AZd7X8E8NqxYimPysDM2ky1EjGst_KYyarzIbefFbWIViOOuKTeLLkyD2G0fFYAhM7S_OZv_kuz8W9AydtWPCpqQodofh7M7uDujFmKYnlgAwD-3O3DJjgwaMSrcRvAFOOT_Hb6kaHA-H4VWOET-1uoRXqOIyaSrPY7RvuzuewQ7zQTb0aseAoY=)  
- [pfizer (1-18)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH9WDRnAN0JC05eb57tPKJYlSHkuEC4QQNE0texUolZROtbyBqolWyj_u3py4ikfGLBkN1-UUlZNMsse2yKV0W58XAsFrW8OImaGBU8E2A6zjgrnOohkphUgVyZ8FsA9JykoRat3f44CxFx7lTZn-CrYk38DB53m-F7ddJLGQ56wA1IVN0=)  
- [pfizer (1-20)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEmzZFVYV3aroFLpKJiv-yxf_mrRXp7Mx67eTbIharUD0TqRHVJpwoT4a5EPxcE8T6wnYeYsI3M-2U9kXrmdB7cLzEyhJLDV-3Blq_2H59-QoeTu5KYXt_1MeflZue9e6K2qDKgCjG9Pr9uc4Aht4cyRMoE_5eS3-hqZ0obeA==)  
- [pfizer (1-21)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHCHNj3A5CQ-ETgoHi0uWjkrU8zidNadDG_xehNGJnYDS4Tqj7dfx6eguH9lpe1izXFqjCdFTHzOS9CLlNcHTh9Y6yeVIcyxXkjqHVSAyymSKgVd1nZLWJor9_0MC5oi7avkPlO_KX7YMNlBKl-8fu4kg==)  
- [pfizer (1-22)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFkQEacDNY7gYwnnd5HffdbEBvTZS0r7KjADO3x0O1bodOBVevKTz154blaqRDGyo8UU_yRyF8NogYVEtA_NVYLVRs9LhBXogWQ1Cwq1eExGHrdVkKR5ke11yAjaELi0F6kkXsatPjKbK-N618-K0nQCymz-zTyxpZGSvExaQcFC3kZT60z)  
- [pfizer (1-23)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF9hTKRyzVApDjM9n6mtg0RRg1BNFAWjxPOLqkG4k7dK3w-QPhmBzdTyWXiU10fQLy8XeDNlYbyax01phYua8u7OFDmvwMhaQlXYAh0DbBA78iC90H13QKdTifTStKy2IxWtSPRGpf5we2RTO8ob4indmq3e9vg5ef533OrjhoTj0Bv1BwwQn08_97YXskQH7yXyv8M68PCTbGH)  
- [crispidea (1-24)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFE1ikpR1drbW-sd-QWhA7ZWkFt8FYEzxjg5bCOjQi0TGlLK4rQmPDEeD60cXjTrtaHWb5Mr_If-tTpEJDgCUTrz2W34TnrBAiOIxZyhC8WEoky8xgVPXnuyNDLcaSxSPx3x-tQBbkTGRC13NzDBy3wUUzKmLKSKEUEGA==)  

- [europeanpharmaceuticalreview (2-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH-SjSVgWSR3Olz2p1v24U9PERRl24HeXRvSJp2mrII0j01EGnvOlFEJ_hdL-0VsgLgcPqPXow_lbyTBscg-oqqkJVxJ3CtxKUCS7uIW5E9Y2uI-xTJ4aIM-Y_hfraITaz4SJKVNCf153N5wqa96qNh_i73OxRr6b6L5KdCT-8JXsZIsmEq4yzezkOgclDDgE5Nq34Sj5yR1TJMnQ==)  
- [pfizer (2-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEXIuwsdJy_6gI8AHPhf3vkBb_IoJ07U9o_65UUBzabK539Mpa2BRZanImTZ09MEYamXGnTOcE7d_9ErDgdLYqGLgQwSVSehfDt2US543uukKY_QeaeHQzK03taaseg3lOi_JDqiMqdF2qBct_k0uuxjEmYybSetfnQfIfBo9RPODi)  
- [pfizer (2-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtdW-1XVJA9YmbmGHeAl5c0kERKxO0-TBnr7WlUTzdpZ9_BrrZmxuele7kdX3JOlftyL_IgxZoOgO99wpkmjdbaccdfNpkKWnMIZxHtq_MejGT4WXksBKrbwHSdRJpkeJaP4LOlA24hNNBedw4bR6tLnyr1ykqDMdkPVJYpDAYY_gW7738XESjEn95f_OIzWBEYO195oe48Q==)  
- [esgnews (2-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGG37v_19Jmw6qthjNCfr1iEMXRUzEb92y-aU9lIfALrBSEbia5o2MuJrWjatFigx9ISq5ra6wid6Sk97pv5IwE6TuOeKGL-1iFpYyZuCi5pzqqr7exk2DcMCW30ZND99vMmckAfLp7lpJGf3xtWksutZSx90nYusKzD_-w1ibvuo-P6gnG1SmNYvWVuTEVStjTXg5YtzQsFZJnp9UOwCK0u6EFo4a9G2gOtoDixg==)  
- [pfizereupolicy (2-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6FkftPSj8ZFHv0fvxbpdmRD0ETKgl-dFd---h6EdDGDX760Tzwo6bV2gfG-wLm7oaxTR3jEoybzf1mEjQmrhZwmTQuBhaF3Cl-kZem-GrbivdqFJMjq2cUedHvSCl5aY4qRaw8UpzhmIbgWkEjZZl5tCLBz_VB_ATUA==)  
- [aim2flourish (2-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHEQ2Nl0HnU_gwRyzzkWdDIcilKNLRwmUQGEm2B1dT8t5QV7wm7Cj5OKmtgMC51-f8aMIFQZ-ukxYhANcJeThqiB2bUaCh-Ak2HVP9nXdZfghGeMmjqcWa46X6sveWrZUQ-sarnIKRBw_l6Hj3fEpL1a53JyTlEdj0S-4nmgpnja5dCPOvpTP6mmKUdeU9gLBrH8X9fXhGO)  
- [scribd (2-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF_p516F3PwLv0N28EhZ4W8Cvg0aYjLPv-v70f0IfEdq27wgMiFrnu1uuIpaau2jCj0EnwnoUBnWYAg4E09lAx6aeL5Rmb2j9MN1-RdWMwGpg55YVvkyrB519pJSsY0LA-lAH1-Zi1DKuPIlRuJottYvwwhI40qQDDldQ==)  
- [healthcaremea (2-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGOPW6RDmBuiu-a7NpgzQMwIXuZWMnIzXzQ72DFFIH0ZKmfM-6gHaWDA8AeEz5tcble9G6AcCFNiXJm6eAUQ54Qg8d-xmoGle3db-kyXxZhWA9iYnvBOs7NhmwiCxlXi-odAoJQjShcOB3TbW-sHQDxkIHKbMrK2q0H2M4P4HZ0tpgx0TL5OkpbBPJZeMllOMoLn4dBrN68lRwKtx5B-A==)  
- [springboard (2-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHUo9KU2bJZxA5Ub0RpDKAw2uR0wqswKbqZ3Er2XTdbMc_F9tUShfaAbqgYqfhTH6eWxvfMkWaN16sR9BWlLZ1ZP_3PN0b7dP3LQQykCqGQHyuGSMpoPYvg5rgMQoeucgtD0c0KeJi_DuK9WkjoFhW_3nfNDsxb93hqu4b3Hqw8EfkxB-fPp7SO2M3M4_9F1vuc)  
- [youtube (2-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFuv77FVeDrb5WF19lzhs_ZCiujUj2CXxfyDSfrB1qohjUsXgmwJgNaSnlG1btpzjl-poGdYLi4vbDnH0nNonhqH0jdeAKiVdZ8XM-Wpw3Li-MME5_8NFOONqnaFROWpRxRpZus47T8Rhlrv-oIabdnRtnRy-503VUY6C0=)  

- [pfizer (3-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEmja5hyNOBIIBz1s1c88TP4X5oO5qEVUSwgy3F573iZbkQdnQelZ8kPNPcNimQy67IEvZCFI2FrW5RMqAuqybuqy4ma2jLPCcJ7TRSnmYCiM6aLN66PFvNxdwEpe0nFBtCkUIwvnLkgGTDBjT6z4sJ72HgEIjxU-X8JrBRYD0hDUeDIJwVyuydRaRXDvY0yVUXjwETnUZRfvsrw2a8aD-Of8LLHqEQ9F9NkXN7Y33UtbuC1ZXq4M4N)  
- [pfizer (3-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEUfZj_K-hgO4sUQYrLII4hNC2_O-f6U7QYwVpUL2EwQRAXmYNOe6lxE1CXNcmQpuVoVLQj_FdvGr5gTJDsz9nTM11M6cE5Ow2vocbDGAvIW1OGtxnwm2bBqhqxrQ6Z8wGjezNQwzRFHF-_681HdGi_FBxxbOPmyDt5K6s68OyDkenD)  
- [net0tracker (3-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEPMbUyOMfpDKUfqHGf_5Ysb6UCVGtB8mjHB4zr9xB2dzaM2ea10m2LcpF47ONdGFSUbeNT_sPAV47uvWgKSdOUczDN1xqISvnJD9YyqfZafNZD5xv4YES5MzPIjg8uavc5feib7n-EKU1iJY6KdJGD)  
- [smartenergydecisions (3-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFcfNv7pkKG5lbdvgdAHIlLjMOoAF4husLjbjh-8I4N3G6IklFgdvWPQzqMITzVTcCpZGNnIosyWIOA3e6eqs0QsPPmi9WvINaMVCdqMBXmi5_H0iaw19wPjYhR8KJUQmfuzQz0O7AFN4F56uRXa_k9RIIgHtzJMbkQoJJVuInielm9XxfRhHjj0dD3fLowuGMOrX6RIm2a2S75eNYFmTzxls0rgj0W_EL9wQ==)  
- [impakter (3-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHcGVybLEj6uqaHhr5wWFK_vQZWujjG_IQjyIndLfekffvrtwFeUHVAJxPK9jw5kqNwJAg3Jbi23vpDDbihMcZG_g3aAxCogoErgbarDfBARaZm-IxLNtd7rbb014bZN6CW0eYdaTv0Ap03RUhKFbZ0B_g=)  
- [responsibilityreports (3-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGP0eeMiv7xbu7AZHt0GNi-Mqz2EXJkwgtOz4d3bTvCGpb6ldoDcoKGAv0CRn3pnavvO1UstRuZPlI3m2AK-u28h5Cq7afHIp-Y7g-Z3eD-HHEnxJLRYts6blqmnxWZVRS2xRoX9BZRPqXRWVKN5B9qHDNOml0IJ-rTBIaekVYW4xllVbSc6XRA9A79AP3OYDWDPlsdOfECQNKx)  
- [csrwindo (3-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFAQscg4IJKSZzx5nZo3Hpk4ev--Q0J4j2qxHuqLdxvoLDt9on9k5HdMc0x1H3eS3g4zrimndnsrsmuemVetEzTI82LOK8yMirbOkhOrWImgY39J23SDC5Vi-cc3Hz86psbooxzTw99wvzoUOfaDOh6W5b8QY9pKDPfUVOxV7WJWHu7I2Bmz0UROBdd9yw2T1VKBag=)  
- [pfizereupolicy (3-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHjD-qQhaMCxIxZbHO09om_2j48Y30v78xf1i3p2W22yWyHZA5hTw8PX5hfQiYEh5IHkl2Tzm1L2i9ofCpJg4y9-Q7WWqTkzejL467z45-LUxh7JHQWm1bFhVRfy90K8do8TxBnMcGU-hutFw3EyM-tyBQfBXe1VdXtCg==)  
- [pfizer (3-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEBTkShvKjIxbtw30YoAPzO-2KR9odbW3W220wnjT1J7PWKkKJ-2ayUDoLTbbz6p-hil1HD54Qyj_1N_vmEwXf9Vlmw-c8gb3C1TT9EghqzSf3t4YwoF4i8xbd_V1XV8GmwEJbD_rCXk3mFPmhYixisZTBoGQxsre3L7flfaVD_DIwJzUEiPY9IcA8CNq0=)  
- [epa (3-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGAzlG1S-bvvGIGhwVbbboKITvtrAoEsum-pC1CIz1sLmpGG_BdKnS4roqmlLjpj8ZTmSevEn7EGwQIjMwUSHwa3CsFz4R7I9gcL9Ui7RkJMDUSYEsqgruwSNYqpwCpCHETA0x-qZgJpcfjFlsbCV3F1ONriugzmZuo8GU=)  
- [ditchcarbon (3-14)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH42cRiwSZImOm6205igDiD8hbiBYXmXSU1MwD6zSzgTvvecjc1TfRXKY85RlMtlsBwhAEGCEx06vnuleCxPUDHCYFX5ZwGz6a0bg_VT0pV_59g8aU6KcyuYNf6-0mI-jUWvK4r6jI=)  
- [pfizer (3-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGRUsL9D5P3c9Zulto5e34eFgsN2VVFhJEfYFgfQSC1GKf5-ePBtwCx_RuH_kDcQLRwlbi9SiI9vppunYm-VV1Somr08ykZ5CSHaZ52VewRt4y9il1YiL5GhKJ7tKy8igf_F6jzI7CSnNEPfg2B3t3tsjf6bUSDp2Niy3gNjEUF5xj2oMd6rz6hXwUmz8bdyq0E5w=)  
- [vesperenergy (3-15)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGGmLgNNpvryQ9O1addI5Tha1GffQkmPAEP5p2r_ZK3svXNt8LuA2rgjm0r038oOiqJ1OrDnSEOav9ptDdYCSI7AS1nlDNt9Hs1swT5wmBVPwq9E8R6IqrEtX-k_x4jIRF7Ji8F5OZn0VuNnAFsUCofBWZwXDw9QXbSSpR8Q7tgzR-3WVUQEUY7YgHsedtO2VrZWjom70R_kFZ8fA0hgvvXKQhujtvQT_nmI-3qj1Eac8J02A==)  
- [mercomindia (3-16)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEXxBN5rjKycbZggjemMrXWapV4_U10atXY6Q0mRkWebltq4Q59I6VD9wuO-nrNq6hRkyUKA3vqIl7FPm7NjS6A2kgvDW7pcVpO5MnQcCE7OW469i2hFdLF3PJwlH-6a-JjoW_AORkM0D3rqvf6K33p8r04r-WuqWnAzcc=)  
- [renewablesnow (3-17)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGCxwwlK_NKjUHrJPUKeEwuv0W_gsrIKf6Kv4fj59srnz8vEPZNHE2DQ9od3nNuuAC82KAG54M7ad1MU4ar28nuxw8UGWOmSOi9QKE4EXusgX53hG70SDQQZdeIeS4yYxfC779OhXZyp5cRdY1Noz6nfXZi0bVmTIjbOxZ6biaLBSv3oStEXwGzKnCsuyZW)  
- [smartenergydecisions (3-12) duplicate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE7UnYghuYgQsQfR-PRR7qrqLmfPk3xIRgTWcBV9ZO6jI3QRQzTBmMwoZGr6gl55ZR1Tm5Piwtx-ejrapzDRvlrSSJAxQZft53jDW-HzYVszT8PKvnrsVR4WxlXpVrAbdh7Le1_fhDoz56TfzlN1NQS_bzXjP4JzE0jLw==)  
- [impakter (3-4) duplicate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHcGVybLEj6uqaHhr5wWFK_vQZWujjG_IQjyIndLfekffvrtwFeUHVAJxPK9jw5kqNwJAg3Jbi23vpDDbihMcZG_g3aAxCogoErgbarDfBARaZm-IxLNtd7rbb014bZN6CW0eYdaTv0Ap03RUhKFbZ0B_g=)  

- [esgnews (4-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFVD7Yjv_-FfCg5pAhqqQpFsxNpjI4JDZ59rU_meZW70zHsh85RuGr5jIH_LeUPCvPidWav0hVBhatqs5wmFCVcvxqRx6LE8Wv1q7vLgzQct8JylOeIljisWxgC8Db79tvRoB0uIDrpNBxnzm4Y3F4IN6Uwudpf9SnB_6X_-jR5TKDdf7swxAsvxjoieVc8soPdulqqj_SWbw0cYdLpv_yHhy_BSDG-GcMZ7yYHiDA=)  
- [smartenergydecisions (4-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH5UIebc6tcpk7fd7EUrhq7n5c90JFK5NU-A5TnjQ3mXgKxhGZjDHmpHqgLGSyl9UCWodMW2Md8GS9wSDWazj3FQDgaM8u5fhaU8baJSEQL23k_5Th3WlkoWf8qA5RlDyiy-MzsGi7ED1VZrOoM8EJ1Xcq2cs--uE_0fyI=)  
- [pfizer (4-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHm5WqHremRPwe7LXMk774hbacA6Gxi5Wp-O490N9A3zpvSNoRPD6lq3P0c0qH1mt_8khIKxWJOM7xpHUUM1OXldMEJ95RZcQ3QEMkLGLonxbGcdoTp63u1afZ29RVTfTO6AO0SQHg3OisSbvJhHYRr5XPraC_pADWAJUF02r87W14v2yYcDPCR3FKYt80OrRfDESbcA6gDzt_HrQEc5Z1YPJmP-8LB89ycjpviNc-n5vOt)  
- [pfizereupolicy (4-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHr-m1m0HRVmFxlP3-iu582kyg8RzYsTddNdsuvh2P-szHADCQaTpOG5XFRDIJlHGgx5KcaPbYxS7TV1SQnefPEXzlrLkGfnAEn-epDzAHrpA9vXYcZWHJd7gZXIbNDa0wufFu1dT8bEh3BKBmSamCQndyWVQvcIMzO0RmH)  
- [europeanpharmaceuticalreview (4-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEQA-dwfW4tbGHXNt5koHuRu7NmnRDhzOt33VhdAYEEJR68hgoe4qgwB5JxlqgyAAdIbS0FX1TClXX8sCMpsLEcaDVpFWOr04QCFHlstVAu1lES0hwhdNS2U7-WGZodTNb3_Afs30bVz3ubB4pEEbku1BkZnQl6Jv72fwYJkEFM5yjreFhk3LWhQ4yfgf0C2C7vp_MKfip64EIQHqQ=)  
- [pfizer (4-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE-atfB5ZGZtsUNuyuniGwOjdKCKwFBzpUKfTU49RjtOSNWtUGCGVpIUHofb_WvnrxrPiGqNDmUDf6i9yG6R3XPC_pOKfg3R9mwozk97wuRa1bHJisBp-xC-0sgaNdRD-uIArAk8sPFk9Yl8sM2EzlKuHe6pYXm8QrTKsJBILOjaoL98EECBusMCeFy1F8UbP05FPu4-DfkcMZzBnQ6mQTX4D59rqorEVDFo2tl4FnwFdQ=)  
- [publicnow (4-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGtPXdudWq87Qcgq53aS8TnJsoYmXrK7enSbWAEFQgCkh7CRY3tBEO_5j2yBPFRpAfLq4bX36t9unes4tmVX9S-DJFReLp7X2yYYH0kk_WVOvqjo9sK7t-LuhIEs9_VGRu65QlTkTbB9IJ8KdKzpMhi8KA5q5fjZJtpOpiTKY-oN-DK)  
- [net0tracker (4-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGkNePaIiciT9xbynsvxx-FcVSsCwLBFZnlKXTh4poQeM6izgQx-Z8iLbJDEApBLSu36mAGBkWzlCD_gZUHOIYYGheImgzoTcPY9gyYESmU5FKOfD6kMlJT2LqCsHPQnuTQu9s5jJnQzFechY2VO1sWHw==)  
- [carboncredits (4-15)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHo7tWCYnVMLu6uyQaqUHwEfcUX08oF9I6ojPNWw3iduE40-9vqylruAuHdZtuf_dJVC_OQVNW-cItSIhjBNAbB1rnAVEG8vkkrwYW1f4CRp6G7lwnENUB4kMmk4PYFMH3eNviyaJEP2M7GL_bDSE4xG86qll_nV3N8Cciz)  
- [pfizer (4-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGSy_YtktfKVydbMI6sfA7QtKSQWTD0GzNGI3WWPtCwiQfyg9hfgInTZzcRiz2rLogyftty0bciZaHbrg1x0fL7xdnoeDqbbNOohGbpO0dwgipgb_itJd_5uboDBpxnSuLMQ4y5YgKJnv2xNPivpkpAZeP_2Dmhn6oaly8gJWYNRmBbUUOFhg2qRWOAnDHH_-rDgwhHvC5qMgM=)  
- [mercomindia (4-17)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEBipexSKtXbQvWR216BoEQOxCTtjVcnm_1ijLgEzsHZCwdLlzvl6bakL6XkSI16zZaOs0jQCFvMQw4K5meOCRhqDlP3HVo7P-73giY_mhOXJR9_GJQLtanqgtoZaC4gFF0Q2u0_VMFPAHyEQ22IV8cmINZJX1Oqan5m2zM)  
- [uschamber (4-18)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHaGfSDq0XRD0dpJIw38fzWQXNaevFdIFjyd_t2kLyRsjFX5WxmDryDAlRq4HpPvKMxkBeYvgRs-izNlgnk8OvG1pCk5MacQOXlF97k5eMq7gEQ0bRi-oqZ9bqNbqcafbtjoCbenGq-dgKWzmEE--Z1oHYqXIWNBJLRcQ6MPAnQdYpfH0QPH_dZyAeKsQ4ANAIVeMwwk5zKP2fX8SfoR8hoMLDxJlPdog==)  
- [sciencebasedtargets (4-19)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHwtroDF5kytbJznJV5muUnRJL2uKWBfcNhH7KMfIsyIRNtVWBGebx4cSUGFoDhDqMuoMU1zGFCFjLMUWyhlEdfhtPK8niZExuuCtqAfueupF6d7VaT9C3xQ1zHw3ZpeRrVZpLBwmlFGcCTvNkkKRDees6OJ7cRZLbNdiFNS4Zd8lqb7KDDow==)  
- [pharmafocusamerica (4-20)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFBbOJvT4hxMRPBReRhj5W2SOGvx7TbH8jI2ZHqARNWyn6dd3y17tLQfvYia5Lc_jYVc-tj_ToUB6WCaZzrU0ek3luluh0eFymhQZaMIbqbyAoUrMKabvLrp2iQqveLo68XYU0IhIBHjvDZFKVG8WEQgsm_VhWAmmvYuT2XlcuGXKw4ggbzs07BokcLTQMO8DRbxUs74w==)  
- [environmentenergyleader (4-21)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHYh3ZliXdT2oXiqC3zInvwXWxY0RYmP9E7APMWSmv4nyFYiPMEE9ND9I9QpEjffKVtBiuep6O2Vi3lLAoEIoDUC7_Kq5vmbPfrVeyr2067zsOGqHMSS9VmMQKmY-QnusUzwQfEbue7La1-1qkonxq27K9dm88IzRpWr4ubSK8l7qhhQ-3W-buAJ7ToUnx-MQUiOxOpVM3eo8Gn_q7hvAata3ij)  
- [ever (4-22)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1Y2kUayh1jb-X7xUJEsj71FNBQF9SbWJ-oGfJs_wcPeHCRhMdOrIb__3ble_do_HxGALY0O9GylbBzF9ovDdENDIobPpZ4gt6Op6SRb2orHXnDJOdg3DGYO_5riGI5o-9kOUvYubwzpf3ag==)  
- [camfil (4-23)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHsFcaP4agXzlv-51QJ7LWQTU7bdEX5IQcOQg_Qbre5iOHZqoJXJkOUWzZfPMxOZ4dkLadhWBmdZLHV-Hqw3vJhWya8pJEspnWLXhntE1eagogP50rWYqyILntCde1QV40i9TQ6tvk-f7baZnQviCjoinbbafU=)  
- [harprenewables (4-29)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGJ1n5yQl46hVBtPoLM0-kqEC4G_Oay9BZdQUArlET5KAJb5GTJTjYtzR5b-IwOY6WyhjNiG-ywBcNyj7-kVOS3NkWS5EG3PKCPPvooYN3Aa0-OgsLRiKJ02LH03RwV5D6n)  
- [bio-focus (4-25)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF2Ti-6GOpx4o9T98HQO0h9IzMahtrMg0JizT86K8pckGdJP1Pjw6X_04PZoIuCGXH385i9T89Igta-x504P1_De6FH5_Bt69wlbFVDp42LU5BNTZ9Pvy6Abpuh2IW3c4eYoLGo51_ALalzu4Z9Q3U3fgxbeFWCyQWGQTjCDiC8LFlf_39hcOXYmYNmJgBoo3zBKV5P7MX0ADUR)  
- [pfizercentreone (4-26)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHRUdgBTpXf04w11GZLd4-ZH81XE5CXswM8qgfgU8tEtxgocYFvc-YXoJssxdWmUQxAlPZpR72ZHI-N73TnuT0IantnFL90irOPbGrkqGM5-yntnPO-93BkyGsnO0TpEBwcJjrNVqRJeIiRQCIeCA==)  
- [dcfmodeling (4-27)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHiBeNeVVs07KLnSL9D9QSb-Nxn7ltjyR-o3LqADEzl5-t1_tTQiJVQKr0xRcK8ZmQkimf_S2ze9m28YLZDHLfabGJI4DDpUWGf8IXxK8vtu_UVKMwu030sZ2wIODbOKCzGVx4YwAO4Reje14O5JQRea105Q6TH0A==)  
- [pfizer (4-31)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHj02SuJWIah8_oXBFK9AJReOAb8tSctCtZg2ga6_1zghCVCcQMTAGIhlf4TMFVYsjvBj9D4xbUcWMf3RSg7ZEGBa2mkRXhJyruOjtFECbTAugh-GLOs8kFyKYAK1GOBpkJOiiK8oMorqkyaR2oezu5MqeOL2Gqnrp3uSPhyxS2juAAv5bX_mi0RswBqWLg5AQ=)  

- [esgtoday (5-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFo7QCCHEF4xSE3epn1TA_kYi0bfoI4_Uk0_pQHyl4Yo9tnD0aulyxmD8886ZbXKtYIBEJVmeK_Eg5sFnAOUEhp_eevpe-3jPEvsNtKiml1gKXLROYTPrtB2EsEHatRi9fFw8-Ojt-I1xDLq_nGDAlCrMAfbzGsCGM3-G0npA==)  
- [carboncredits (5-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGbzRjUv1vSldSaEnOvOfzYF4jJUChCH8kzkNK75OtWp0HyjmihPJ31bWC3-LovHEt8zJpTlP2NwFPpaPy0EKCXouaSGwlFLosGCBHxaaKpMne7-pHFiBGXn6DIv4ywJdgjVuDcUQF_y2Bpu4Z11kqfqQ3WP7eu8PNz20w=)  
- [pfizer (5-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF2_nhZ7WOuihAnOg2lOitW5xQSC7XOTwufG55WW05f3fz9AM9ao6fXawHtVlre-5mhX6SqdNEBsIVlHuJV__LkhBaeXES3qDJb5cVjtDcWNF04XycvBDWha3hdM7UbycPdRrEnkZc9xZ5rL1lyu7G4atbgaMTER9SIi4unRr1eVYQstRrXzEFxMa_4dNVM51nfKCCgKV1N23jMxlfh8as42WgEeBQ9ugNfaJmTP1Z-lg==)  
- [acs (5-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEVGDAbOeolgxkdgEWhxzkHDiscyvnAash4N5sbutMwBCJLpaKFUYjMvVvyRgzRKVsmjMeVpOZVjqeKIxkqob4dvDhzsXwP68nf5uNoGjdwydHCzsO2eYBrBuyPhR5Sb80gLJv4VICbDnWr4-ufgCZEWRoa96m1qqeKFvhBqdI1SgrgxbOSlYAwdBw=)  
- [impakter (5-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH2nBjMwOul7GIkdrCcXxDLOyMFvuOSxP_D1qoqKgZR2PbzBV8BfQh_hAT9Fu3tVAFOmkt8JpizmeAavjBtftRLCpYS6aTQV0ryelH5__Img4t8P4FK7xfsyXZ8wFErv04VKhs2ZphsAskxjHKTFofYZjM=)  
- [pfizer (5-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHcPjSLoSJlUILA8uGrzCLDo8xEjiOSJxVeI8iTJtal_UUZolElG7ItwOCt5G4rvKkJuat_dX7xFMNB67U2ODF4hIZZ-R3Ng8-9Nch_VKhK2CDiFEEmDneiztQT-LD6r5Yz)  
- [bioprocessingsummit (5-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEgO599jKHS-TocVt0NPlw8Vsgo9PabPZr5I5j4UoWv50CVJaI1aFKkL_LFjQkhiJGkMdDZEfOiGEbK2xQBc9tNv-cxL8E7dEsdSyTWMqwb6iKWkt_13DO_mvgi_DNNac6T9dcx8bNygt37X-I43QAhqca4OiJo)  
- [labiotech (5-16)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFC-xHNRBEO23GJ7NCArqZvOQ2MSoPbtWC2t_NruWGBvImsu2d9M1eZz8f3Zyn6Xa_uAbesLyfD0l52bf0YzFo56juyP4ubkgE4kJDiQJvGSXPrTBD7yVa6cLHe61t0PamNZOrp82d9LMZatS3HiK147M2ZcrTp7Y2W7wwgfhA=)  
- [crunchbase (5-18)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGW03dPW2bTF2e48-ijTBOHagQffxPKkd-5T1fJhtuoyhWGQrCkHFDvlcHXLL3O-7MhgWkhCqSgado6NRQatrj9DrFBCEQpv63bMDojCYeaBO7dM6um3QokgNQ30cjAvygEhZSmD_14P05J_QhJbnnGFjOlCtsKxa6u3gm9dssxMrWxjgLczIovJpksFRBTS5onsrUOFyifsOK9aJfCb_d4-4E=)  
- [aim2flourish (5-19)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH9fezl18gYbJ5RYJCc13I1pUl5JHYzCDOwyFHzuPKWNAhcb0zm1W_JTANW2buk04Hv0pAm0JDdKYW7LD1qXfkRs4R65p_B6OYCo7TinvnywIpLRQ_GBuQyQRVi-L1Ife1Ec7LfM9DnoLJ5oBVt7uQz4humKFM7q-IUPSLoDV5TE7s5TuVzaAWUgjJ2y_6wjVaoXl81F2j9)  
- [pharmafocusamerica (5-14)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGt1awUhvCR-dwkCvjHfS7GC9Zru5QAfr8E3dAWgu5RvumC9CsibgAAxxFx8ybDpiZURmUyhuoXPz1rOwNWeVb2esQyQj7xFv3vRhLn6eDFbPNJrzcziR-KVr7eGp9RscXGxnkNTx0Ne6peuLIVp40kff0g7sFGEg_B6LcALFNlHlyq9FYGg-TKFAoQgwSH0r9jGMuu)  
- [bio-focus (5-20)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHICuy2yWIEFsB2DOGkC7biz8W0v3mRkuPHNl4zsgBizwcSz3cbrPCSUuVMd_ZZyz3HAPT0yJ332xqbnDVNtyk0I5_tQjwpqNA2gYe9cHjEBDUBJvSFbGRFTK0nashodRrlFQVcdvy3kuw2_InI8qJbTyo_qwZlZdGUiLzBujq700VQo2rzklnfLk04Vqmb3qzvEK7c3l9UKKFNBvpXyTUpm3bD)  
- [pharmadispatch (5-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHiITX9bwklYz2brj5hsHEN27O8RCBf_HSZ_H6Yv8sdjN-4eN3KBo5mJl2lgIAXjdbs1bxkstJr_duvHpXfEWsOLpP3-g3XOyYbVxlbXMQa6mmrfwiv6mV831bbCU2rJrltpsDVNkLnVl4dt6fcTppzvSxYY7Em8yHPeZM=)  

- [esgnews (6-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8xhbX12_oqwPhB7e4C-U0qvVxWeDraxr6XgNCI1VNEJNWgF6NFFZK3NBfNqcfIlvoMogU6NmXMGHeYb_aqYIPg-L-FgMYYyids2zxYB-XO243ttL2gkVgKJ0nHn8NQDihVJAtPRRU40hSxLHHfAViasIQLZF7eYi9XyzNJPg8qPV737GRmpH9mtuH2IogW219dKmBPiuarQ3eO5zLFr-zdv71JAgFA_078bszTQQ=)  
- [epa (6-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEsSWrwVTBI1-RZ2CAZ1cF39BtvzUEM6ashvyXontO78h8GeGqQftCC5rjziVtx8IBq5-B1amez67ZeIGOjz-knA2vItsm5eevZKFPPQR5scVjbhlWSyfnMk-gqqieN9aITs87IFtVjet-5NWOM-JyK5hN3G0jp_UbXwl_p)  
- [pfizer (6-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFa3u8OBJLUjQtl6LWEUeGc2JH5ORv8kq4v7FJvIvKHdHdB5Aum6YGiUGc-mHuY1i3BBKcUEQqZUFKg0mKVP3ca6DX9AsnTUWfqcqESzGGOS0uRyxlznze-PDKnmYMEykpNr8jcanwMYiIBlD425ptEuDSiFDdKemHK8t0aUODGl0BeIg==)  
- [impakter (6-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEXQcemX-JwRhs0oae83xxvPLAI4XKZn3_nfugGSqvScyTsW0QjDf-SUUDZvRItaXKaTXJ5cdogRtU5RErF5aeMEwL3iWhD3qrz4CHrB40R3V1OIAGkJbJ2Im4UW4X3FpSVtX5ZKA-_H4-cJvAEVq6EK-Aw)  
- [businesstravelnewseurope (6-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHk4r3Vm22bqzECKEoWfTrUaM7tRJHqSEokhG321dVVDUt5t3cBsfHofwqPWVBMJITlMhqKb42iEH0mMRfoYeNR3KWzKn8frwFBEUlVj3pQ_UtnpZhpC7d41o2Jg7_WGenHttd3jdEmFz1nYUecY4cZAXQ9rwI=)  
- [ever (6-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHgI5j3715N6R5ZJ0a07M90af0ma0dhDz3FobaxznTW0xPCCoDlUKrSZ2c3ZshajfKLSzqRHNj5J0kfN9eAGbLPtToiMS5qO9ltRS9lECZtEZTO09X4BIkSufPBOAtJqSp67GLNgXsgE29ZQQ==)  
- [siemens (6-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHWryn8xQCMM4knWyQznujD0ecgLwdeamkj79ge-uqRRSIoC6vutEhbIYuhEHXI_utlRa2qyapFYy0cfqtYQYFFUvKW64yhHuuzsr26OZXKDP-8JVBh_SvWYoqEsrLFj62y7rRO7WhC7Ocy2_DPN6Ir_p9HOxEVjRr5ELa2ZJC79ferccr2kvtBF761VEkEipG2R72yFbLHOA0R5DJjBImX4yO91Bbe7bRwfJ6MHiLkyJsxqqqICxHkG6q297Xj)  
- [pfizer (6-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFrDUvG15JUlQBdHE5AJg1WgzDK7eJ9wPBNdEVF4szU7yNntKMFPrFHDiQRvg1yf8bRIxN3z6RkBpvzjaC488NZIR0gERDhkmiKyFD_cMDBFXJgfrNAQ_aHyn-vjXG7x8anIcjaxjVkjwqARRJNJ1F1xbYy4jY61xi8lJEyzb8LW5vUZaXaCp1ivHHWCJfjlOI=)  
- [pfizer (6-13)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHU3-yef8etHzo4E9ZDfQCil-dv9YPlM59lQd1Jiautc6i6Hk8y4zmWxNt2PKJXVV2jUGVVTZKgaBxlNOrj4vZ8qVKGVbz4XcVyZIZihrBEVKheEoqwI3hB17wln747sygZqmtiHqF2lGmiSE_NdbsAAsf1qVNH2RQib44T2598d2ru91QWG7-A)  
- [nasdaq (6-15)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFIgpigfUXddXfaaPIoD3nCw_K4od2PxusPQssp_wvTS3h6dh2agHSdw_kTZAOd8wmDNkEckqIVhW6XwpjvAcxeBzRWU9SD8m--KOUbayxnNyPd7MHu4Me4ihL1J9u9g7RpqIEyjUqR48FYm-OHY23TmdgrT-je_mQwWfR_N_kBshuFSdf7ydWK5_U2TLkAtCKvbZS0wdDEfuJSfKjoA45s1ZR11hrnc8EyV8QEX-3ZgujNzQ==)  
- [monexa (6-16)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEF4Zhda1EyEPDJ58pg2cNK2jnERwXtgI0eRrlW4kvK-n8la8V60HiEjUuf_s1_TLd8fpgMNz_AmdTGk9z9MHYBzwUXOdyZLfvLHtlb6abiLMdAlPmZgMlO73Ab5GfkTH_F60JuEBgavKmdSwAFNH9QKdEsIkVCCdDl3uzKEieD6BDagEskzN1-Ws7EVzlag_7cmXo-yYS0)  
- [uiowa (6-17)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEH3pH1aFxFBHeOoj_v5YGLYrCr3eFAnQv7IW6oQkhva1_y6BoPPxP1KzK3nO-1fXZGgvYt1a1z2WUQniKRj4r8u1maRFzoDVGQQuO4HCHDB4eSJu4vEjcXKiA-_Z3x6eTOGqFBFHaGv2t1Dphmz1uhe-hsGrweqqwJT0dlXniRTte1EMrFx6ITaw1MV4q57noLQ4qBgVc=)  

- [pfizer (7-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGnHkJdhWtOSP4vjeHObIMiggoD2ti_zbBvixD2V130wOgwkgTE8lrTSMU1rlnZWhZYe17tEZZfa5NIJhmHpL6Udd0nd1v7ccwFAE2rBCNElBKR68M6KWJMWR5TehOVF32jtyx_kLMtlrkfDSvP6J6kgmfemUU8D9n8J01lUNVBQa8kKvWswfXibk2ugi5q)  
- [net0tracker (7-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFV4GFZz-FqlXQ7VfbqSxCKguxE6V8OiuhfLGIrKJwsWuSUaR3VxN5ZaUqrFg8CgAqTOCOqMunTIw54yRcfEDt6paXo-KvDDJxvd7FTSwbrrVZJSe4MH1Tsb_ee6081EFiJchk-igVVf_PdVxWUc2lTDw==)  
- [carboncredits (7-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFbgmI29JLI6W_TDvM23eXjlMrR59TIYgrF9mgaA2ilnaGLU996zIb38a4C48IUdk7uOrwNkm1pnlHdeTmusXAtTLnHGj8Vi_RihQDIQfgpsfnz7ID1fYfTpNmJLVc3K35DfC8484jUka59eX0J47ZxSRHZnEvUIYcBbmu7)  
- [sustainabilitymag (7-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFSf_jk2a4Kuqenm9-H8vBG55MK0kDGPxnpK33uTJiEw8G1AXCCTACP4Ga9g_v5PfJ-FhJZT6qvuUbf2bvlKLpsMTeJwmLyUyat-9SAM9cHJdR7D032-mdVOqfteuTO7-l6rXiN21Us8EbFMS_iN9sbzWBi5cr0zyOJFmqOafoqhQfJ__zLQsd4_SMCCnwXP_PYwD8SPWsr908=)  
- [theenergyst (7-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGMD2zr8ilpTDyl5W2EDXKvKWWqJErR9SJXNErqzOe7yNbdLTA7mGqvtMRTDrqa9ly9h65F2isvmLf_6kkccyzo7EtWNSaQj3N8dT-cSas3dgdcXsU8v05-CB3abiL1lAPTljjSjhSIeooe_BPp-orHvgAxqsL6iPeF5dK2Gq_6DyXBcrvOBnx7YqfRwQ==)  
- [gsk (7-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHpflUZ_GDLQpcF2Nu2keu8TU9iVBHkiFqLwImS8ONavo1a1_geCO427Ahfa9IyL7lauGIVqMa_gk_zrXkeirqWICBvlDMcQ3_Pv9L4GcfpdWyH0ef89jiEKViJUxMWIprm10d4sp6vtT8OlUR9KxVKdl6RCY3hYSI=)  
- [cesltd (7-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHyLsAGWAYk-_rQ_bhAmSrDOtavulmOVNgvFpuM49UxzyeAYTZWqtIfI_ovI-KMxvbcvRMa5gWqlFVur1Fs4Q2hnMOi0miel8hfryzc7rFxenqitN4iOvUVLzZe0fYK4tY7zD0B-jsVmO7tj-qp3IpFKEILQaGZ320HR1eN1XvWkQBrzUGuXa-X9edJX6eVc6k=)  
- [novartis (7-12)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFoswd5AF0yvf7r5nPkwH4d3twJiAy-VN3cOKEkp_xdbPZw3BmC7WcZK2hohfnP_NKr4de9jLJJC0WnbqJ-w8bhYEKLjQCfAFZKDFMt6YZsK5gWT5juqRwF7s3Bzmb4omyR3R_yJd_G-H8epoyOFs1gQbFyNNXXSRJCaJkPgkkqfHJzzdAFwWXUguasjPqCZeJtAtcDxlM=)  
- [druganddeviceworld (7-13)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHlwg98ZUiPN4e2ZDzFezmDBKPQP3TfHZcIX3uIBCji9RQjrW4UYcvSldYKXiITNyBXmE-dBJwZHthMnh97UKMOZ6QRxGQFpygIPSr8kZ3c--ML1nEUbK5rj3Y4rL2Zhus44kK9mzRUCUpA8gg33P5h3F2PR-2CMSQFnJmgEstzhMtNuhdWKqgI-NN09xWYQA0XVyuB_vyS)  
- [jnj (7-15)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFjsekejASMzMdnn90nbULdeLlSuF5ybYEgkcjogVEJpstpydJOQDd4NedMUeb0BaU1aX-LQnPhPDPNbHkiYzyx9YvZgsJZ2j8z_PUSslYJa676-cCryU9ekHuycc3siE_ENi-e279XkKM4UBEmcwApvKtEwSKeqMRxijkCowZDpajcPatGQ5TVsxG4t-n1u8pGQLBMEqqPVIYFQrJKRcVghltGzG8=)  
- [thesustainableinnovation (7-18)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH_J_fFoHrds4L8kkcKTZs7DU85W8rvIWMh26l4kGCxX4aBJm3BtByjxx_3pWco6sUOYqJIoVYURZ-4yGIO42KIkTBLaJR1DXIfUXl__P13f1ql2skNjXo0eM7-CVAwOFofusP5kwuMfg97kIRPp_ik)  
- [astrazeneca (7-22)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQERe5HJ-V9au5iu8YVYeML7SQszqi9A02eiZdisU0MK7eGHFVuQOtOiuUptyMj7wfZU6RrQcLN3WlpZ-MNtwc_8mIDQmlhzUFMoqWQMXdiALPhKY_Pr64VOpyOAFFRq1QszUGzCw9AdHijQs7r5luGU5zoQA8dBOQD2)  
- [sciencebasedtargets (7-27)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfLde1SgbrntN4yZI2-cd7VPmePDvHnjEGic7yZGZ0mHhG-RpRvmWBYpB2dzS5CY-P5gI3RuBlVkcS2xf8P4Nj371UxW23fTfKXQXhSqS-YVoUg1Jgap98F3YlFMKh7RodBhe0fpIJXg-LdgY_KYgKkYTNkJB2MQMRcx96RShybDyplMgOgI9eZ56iAo6u66VrcunXjfpGr6032-FfMa4=)  
- [netzeroportal (7-29)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGWyGObkLJhu2LJB2XpqjeWvTmFLrjkDb2idrmcdXWBhg53SthnMbt7b660wrK8RBd6yoIM0-p8PM2URE12HW0GJeVVF02kUFLjNjyFogOrnQvwmF2AMZ3j0LZS8OxQcCPw6Ow_s4E=)  
- [ditchcarbon (7-32)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFz3xrpp4PWLV2fG78vKxvbefXu2cElaEkCDciS26UrsmDWsj9C4Zj_xFbS6xzRHRoiaVeBKR_AQQjAKalvmQOO61-drcMpc7tRTygUqFwgXgzRbk31BqKd15a2PX6IBC1A1rkUVXSY)  
- [procurementmag (7-16)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQELc3bLtXaURWX8r2E7frtaZl8x1aziVjRJhzM0Uq4saZOvZSDUiyvb9z4ah1FETwR_4l4iCZhtMdbRdTVoZcd-GtZx391WRL2oFZVQq_RfwNplmhzMWzYineppLToVz3gkPKN6KqCuhDu2s7DcRs4zAQofZTGFik-LTEQgA-vZJsAfltkhUw==)  
- [sustainabilitymag (7-23)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGXKYUp7oJ8pQ8-zYA8MlHqq2LZM6atWtsKP4D7GSg8l8NmvceRlEfx4wNXozgKrbPJ3ZE7SjYJSwPa1GSRJrOkjHjgmtqoW7crNKoOWf0FLX3mzoFkJB_sNlif_i7jcAIT7lQnUzlrtZ4WriL2-i1sIux0_-0Fyy4j9v-mbchnAB0SDov13s7PtLLik5NPgUY=)  
- [procurementmag (7-16) duplicate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQELc3bLtXaURWX8r2E7frtaZl8x1aziVjRJhzM0Uq4saZOvZSDUiyvb9z4ah1FETwR_4l4iCZhtMdbRdTVoZcd-GtZx391WRL2oFZVQq_RfwNplmhzMWzYineppLToVz3gkPKN6KqCuhDu2s7DcRs4zAQofZTGFik-LTEQgA-vZJsAfltkhUw==)  
- [impakter (7-34)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHEvdX0IN4WsdZ6mx-ItaE7WCT5f0zAJSuqXu5Tm58ODLna-kwNf6G8glACtiJa1_rtlmINIP87XuBrBdDMchELqGvtp8JANtG8M2YTF7I45VbVGA78EpAbZ8YDT_1FOYcm0kvO3YoTdPBk7Ep2K5QX9k9n)

If you’d like, I can:
- produce a one‑page brief that maps specific projects (site, technology, commissioning date, reported kWh / tCO2e / $ savings) to Pfizer’s 2030/2040 milestones using the primary source links above; or
- run a tighter peer comparison table (Pfizer vs AstraZeneca, Novartis, GSK, J&J) showing the exact renewable electricity %, Scope‑1/2 progress and net‑zero target years with source links.